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AIMS AND OBJECTIVES 
• To validate the  Paediatric Index of Mortality 2 (PIM 2) score in the 
paediatric intensive care unit of CMC, Vellore
• To compare the performance of our PICU with the other intensive 
care units in the world. 
                                        Introduction
Paediatric intensive care is a rapidly developing super specialty especially in the 
later  half  of  the  20th century.  While  these  developments  happened  much  later  in 
developing countries,  over  the  past  10 years  there  has  been a  tremendous  growth in 
Paediatric intensive care in India.
Paediatric  Intensive  Care  Units  (PICU)  constantly  aim  at  promoting  care  to 
critically ill  children which often involves huge amounts of technology that comes at 
exorbitant  cost,  often  unreachable  to  many  families.  Even  though  the  underlying 
condition is potentially treatable, the outcome is often uncertain. 
The question of how best to utilize critical care resources is one that challenges 
intensive  care  unit  (ICU) directors  on  a  daily  basis.  Shortages  in  space,  human  and 
economic  resources  especially  in  developing  countries  limit  the  ability  to  provide 
complete  care.   As costs  of  health  care in  ICU have gone up dramatically,  correctly 
identifying those children who are salvageable from moribund group of children becomes 
necessary for implementation of effective and rational medical therapy. 
The  Paediatric  Intensive  care  unit  (PICU)  at  Christian  Medical  College  and 
Hospital, Vellore is a multispecialty unit that provides services to a heterogeneous group 
of  sick  children  from  various  paediatric  specialties  including  General  Paediatrics, 
Paediatric  oncology,  Paediatric  Nephrology,  Paediatric  Endocrinology,  Developmental 
Paediatrics,  Paediatric  surgery,  Hematology,  Urology,  Plastic  surgery and Cardiology. 
The annual admission is approximately 1200 children per year from various parts of India 
mainly comprising population from in and around Vellore including adjacent parts of 
Andhra Pradesh. Since this is a major tertiary center, most admissions are referred from 
various nursing homes as well as medical college hospitals for further management in 
view of  disease  severity.   About  one-fourth  of  PICU admissions  are  post-  operative 
patients from surgical specialties.  Thus our patient population represents a good amount 
of case mix and disease severity requiring intensive care. 
Infectious diseases,  respiratory and sepsis  syndromes comprise the majority of 
admissions  followed  by  neurological  illness.  Majority  of  the  patient  population  are 
infants.  The overall mortality is about 20-25% which is high compared to figures from 
intensive care units abroad. This finding is probably related to the patient profile as well 
as a greater load of sicker patients being managed with scarce resources. 
This has compelled us to do an outcome analysis by predictive scoring system so 
that accurate outcome data is available for guidance of prognostication and counseling 
the parents.
 Literature review had shown that there are two important scores that are available 
for use in Paediatric intensive care units. The Paediatric Risk of Mortality score (PRISM) 
published in 1988 by Pollack et al. is still the most widely known and used prognostic 
score for evaluation of disease severity in children.  In 1997 Shann et al developed and 
validated  the Paediatric Index of Mortality score (PIM SCORE) which was simpler to 
collect as it had less variables than PRISM  and  performed well as compared to PRISM. 
The same authors published a revised score in 2003- PIM-2 which was better calibrated, 
safer and better adjusted for diagnostic groups than its original version. 
The PIM Score which was originally developed in Australian PICUs, has been 
tested and found to have good discriminatory capacity in intensive care units in the U.K 
and  by the same group of authors. Other studies from Hong Kong, Argentina and Italy 
have also shown comparable results.  Limited Indian data is available in the literature. 
The only study from India  compared the performance of  Pediatric  Risk of  Mortality 
(PRISM), Pediatric Index of mortality (PIM) and PIM2 in 246 children admitted to a 6 
bedded PICU in New Delhi.  The area under the receiver operating characteristic curve 
for all models was >0.8. However all scores under predicted mortality.  
We expected the patients in our ICU to be quite different from that of Australian 
intensive care units in terms of the underlying disease, the severity of their illness, the 
access  to  health  care,  the  amount  of  intensive  care  available  and  the  health  seeking 
pattern  which  is  influenced  by  the  cultural  background  from  where  they  are  from. 
Moreover, nutritional status of the children will be very different and will be a major 
compounding factor that might influence the outcome.
We were interested in determining if the PIM score is applicable for our intensive 
care unit with its patients as described.  PIM data is easy to collect and is available on the 
internet free of cost.  It is done at time of admission and is independent of the intensive 
care delivered to the patients. Hence this study of validating the PIM-2 score in the PICU 
of Christian Medical College & Hospital was undertaken.
  
                    Literature Review 
The provision of intensive care to infants, children, and adults increased steadily 
during the latter  half  of the 20th century,  with particular,  rapid expansion during the 
1970s  and  1980s. In  paediatric  intensive  care,  the  growth  in  activity  has  followed 
somewhat later. 
The  main  goals  for  intensive  care  can  be  simplified  to  save  the  lives  of  the 
salvageable  patients  with reversible  medical  conditions  and offer  the  dying  patient  a 
peaceful  and  dignified  death.  Correctly  identifying  these  two  groups  of  patients  is 
necessary for implementation of effective and rational medical therapy. The escalation in 
health care costs over the past 25 years has paralleled the development of specialized 
intensive care units and the recognition of critical care medicine as a separate medical 
specialty.  ICU beds make up about 5% -10% of the total  hospital beds. In developed 
countries  such  as  the  United  States  of  America  the  total  health  care  costs  equal 
approximately 11-12% of GNP with the total critical care costs representing about 1% of 
the GNP1.  Similar data in the developing world is forthcoming.
Thus outcome analysis by predictive scoring systems has become a growing field 
of interest in clinical research conducted in critical care medicine. Two important reasons 
for this are the rising cost of health care and the need for accurate outcome data so that 
patients, their families, and physicians can make informed health care decisions. 
Utilization of the intensive care unit 
The question of how best to utilize critical care resources is one that challenges 
intensive  care  unit  (ICU) directors  on  a  daily  basis.  Shortages  in  space,  human  and 
economic resources limit the ability to provide complete care. As a result, some form of 
selection is necessary to allocate these scarce resources among the individuals competing 
for them – a process termed rationing 2.
Rationing of ICU facilities
Rationing of all types can occur in ICU setting – rationing of equipment, staffing, 
medications especially as ICU is the site of application of most advanced technologies. 
Admission  to  ICU  often  serves  as  a  signal  to  proceed  with  a  continuous  series  of 
interventions – a process that can be difficult to limit or stop.  
Decisions about which patients should be admitted and which patients should be 
rejected may consume relatively large amounts of time; in fact, decisions about how to 
manage a patient after admission to the ICU often are less labored than the discussions 
about whether or not to admit the patient to ICU.   
The imbalance between the supply and the demand for ICU beds and the resulting 
rationing that must occur justify the need to develop formal guidelines for ICU admission 
and allocation of this scarce resource2. This is particularly the case as patient selection for 
ICU admission often must be accomplished expeditiously, on short notice, at inopportune 
times  and by junior  members  of  the  ICU staff.  Unless  specific  policy guidelines  are 
developed, implemented and adhered to such decision making becomes subject to the 
variabilities of personal biases.  
Establishing ICU guidelines is not as simple as it might seem and the process 
itself reveals ethically troublesome issues. The information available for sound decision 
making is expanding. Protocols to evaluate the outcomes of patients suffering specific 
medical  problems  have  led  to  the  development  of  scoring  systems for  objectively 
quantitating severity of illness and predicting the outcomes based on specific underlying 
diseases  and  physiologic  conditions3,4,5.  Although  this  information  has  improved  our 
knowledge base,  the incorporation of this knowledge into decision-making process of 
ICU management remains complex.
Scoring systems versus  randomized controlled trials
Although rigorous experiments or large randomized controlled trials are the gold 
standard for evaluating existing or new  interventions, these are not always possible  in 
intensive  care. For example, it is unethical to randomly allocate severely ill patients to 
receive  intensive  care or  general  ward  care. The  alternative  is to  use  observational 
methods that study the outcome of care patients receive as part of their natural treatment6. 
Evaluation of Outcome 
Intensive care has  developed over  the past  30 years.  Without  enough rigorous 
scientific evidence on clinical evidence, doctors delivering intensive care often have to 
decide  which  patients  will  benefit  most.  Scoring  systems  have  been  developed  in 
response to an increasing emphasis on the evaluation and monitoring of health services. 
These systems enable comparative audit and evaluative research of intensive care6. 
The evaluation of any outcome requires performing two specific   processes. The 
First,  the  outcome  of  interest  should  be  clearly  defined  so  that  it  can  be  measured 
accurately  and  second,  methods  or  techniques  should  be  available  to  predict  the 
outcome1. In most outcome investigations involving critically ill patients, the outcome 
measured  has  been  patient  mortality.  Other  outcomes  representing  important  societal 
issues have not received the same attention as mortality in critical care but include the 
effectiveness of resource utilization and cost benefit analysis of therapies and diagnostic 
modalities used in critical care, the resultant attitudes of patients and their families in 
regard to critical care, the long term quality of life after ICU care and the systematic 
evaluation of the process of critical care as it is being administered1.
Risk Adjusted Mortality 
Risk  adjusted  mortality  remains  the  commonest  benchmark  for neonatal, 
paediatric, and adult ICU performance7. Mortality risk scoring systems are integral to the 
provision of modern intensive care, providing a measure of performance both between 
and within individual intensive care units over time. However, before inferences can be 
drawn about  outcomes  of treatment  in  such studies  the characteristics  of  the patients 
admitted  to  intensive  care  have  to  be  taken  into  account.  This  process  is  known as 
adjusting for case mix. Scoring systems are aimed at quantifying case mix and using the 
resulting score to estimate outcome.
The death rate of patients admitted to intensive care units is much higher than that 
of  other  hospital  patients.  Given  the  relatively  high  mortality  among  intensive  care 
patients, death is a sensitive, appropriate, and meaningful measure of outcome. However, 
death can result from many factors other than ineffective care. Outcome depends not only 
on the input (equipment, staff) and the processes of care (type, skill, and timing of care) 
but also on the case mix of the patients. The patient population  of an intensive care unit in 
a large tertiary care centre may be very different from that of a unit based  in a district 
general  hospital. Patients  are  admitted  to  intensive  care for  a  wide  range  of  clinical 
indications;  both  the  nature  of  the  current  crisis  and any underlying disease must  be 
considered. Intensive care units admitting greater proportions of high risk patients would 
be expected to have a higher mortality.
A valid scoring system must predict mortality accurately while adjusting for case 
mix and disease severity, but also requires data capture that is feasible in clinical  practice, 
and should be updated to reflect changes and advances in ICU care7.
Measurement of Outcome 
The essential characteristics of an ideal predictor of outcome would include
• The prediction rule should have a well defined biological outcome that is easily 
measured and clinically relevant.
• The rule should be derived from a broad, large database so that it would be 
applicable to a large number of patients. 
• The error rate of any prediction rule should be well known and its significance 
well understood.
The likelihood  of  mortality  assigned to a  patient  by any predictive  process  is 
termed  a  probability  estimate,  of  which  there  are  two  types  -  Subjective  probability 
founded entirely upon the knowledge of physicians and objective probability, drawn from 
databases of compiled clinical information. 
Criteria for selecting a scoring system 
• Proposed use 
• Validity of score 
• Reliability of score 
• Discrimination of scoring system 
• Calibration of scoring system
Evolution of scoring systems in intensive care
Paediatric  scoring  systems  can  be  broadly  classified  as  in  table.1.  The earlier 
scoring systems6 were developed for trauma patients and were either 
specific anatomical methods               Abbreviated injury score, 1969 
                         Burns score, 1971 
                         Injury severity score, 1974
              or
specific physiological methods            Trauma index, 1971
                            Glasgow coma scale, 1974
                                                              Trauma score, 1981
                                                              Sepsis score, 1983
A brief description of important scoring systems which are in vogue follows. Description 
of scoring systems pertaining to the study will follow. 
The Abbreviated Injury Score 
The Abbreviated Injury Scale8 (AIS) is an anatomical scoring system first 
introduced in 1969. Since this time it has been revised and updated against survival so 
that it now provides a reasonably accurate ranking of the severity of injury. The latest 
incarnation of the AIS score is the 1990 revision (Table 2). The AIS is monitored by a 
scaling committee of the Association for the Advancement of Automotive Medicine.
Injuries are ranked on a scale of 1 to 6, with 1 being minor, 5 severe and 6 an 
unsurvivable injury. This represents the 'threat to life' associated with an injury and is not 
meant  to  represent  a  comprehensive  measure  of  severity.  Organ Injury Scales  of  the 
American  Association  for  the  Surgery  of  Trauma  are  mapped  to  the  AIS  score  for 
calculation of the Injury severity score.
Injury severity score (1974) 
The Injury Severity Score9 (ISS) (Table 3) is an anatomical scoring system that 
provides an overall score for patients with multiple injuries. Each injury is assigned an 
Abbreviated Injury Score (AIS) score, allocated to one of six body regions (Head, Face, 
Chest, Abdomen, Extremities (including Pelvis), External). Only the highest AIS score in 
each body region is used. The 3 most severely injured body regions have their  score 
squared and added together to produce the ISS score.
The ISS takes values from 0 to 75. An example of the ISS calculation is shown in 
table 3. If an injury is assigned an AIS of 6 (unsurvivable injury), the ISS score is auto-
matically assigned to 75. The ISS correlates linearly with mortality, morbidity, hospital 
stay and other measures of severity.
It's weaknesses are that any error in AIS scoring increases the ISS error, many 
different  injury patterns  can  yield  the  same  ISS score  and injuries  to  different  body 
regions are not weighted. Since a full description of patient injuries is not known prior to 
full investigation & operation, the ISS (along with other anatomical scoring systems) is 
not useful as a triage tool.
Numerous  other  predictive  systems  have  been  developed  to  forecast  patient 
outcomes in many clinical setting. Examples are the APACHE (Acute Physiology And 
Chronic  Health  Evaluation),  the  MPM  (mortality  prediction  model),  and  the  SAPS 
(Simplified Acute Physiological Score) aimed at the general intensive care population. 
Apart from these, models have also been developed to focus on the paediatric age group 
namely  the  PRISM,  PRISM  II,  PRISM  III,  PELOD,  PIM  and  the  PIM2  which  are 
discussed further on. For the neonates, scores such as the neonatal therapeutic scoring 
system (N-TISS)10, Clinical Risk Index For Babies (CRIB)11, Simplified Newborn Illness 
Severity and Mortality Risk Scores (SNAP)13 the has been in use in neonatal centers.
Measuring severity by treatment
Therapeutic Intervention Scoring System (TISS)
The  therapeutic  intervention  scoring  system3 (TISS)  published  in  1974  was 
developed to quantify severity of illness among intensive care patients based on the type 
and amount of treatment  received.  The underlying philosophy was that the sicker the 
patient, the greater the number and complexity of treatments given. By quantifying this, a 
proxy measure  of the severity of illness  for a patient  could be obtained.  The system 
scored 76 common therapeutic  activities  and was last  updated  in  1983.  A simplified 
version based on 28 therapeutic activities (TISS 28)14 has been published and a version 
for patients in high dependency units has been proposed. Another approach is to assess 
the severity of organ dysfunction based on the type and amount of treatment received. 
These organ failure scoring systems are used to give a probability of hospital death which 
takes into account the severity of dysfunction in each organ system and the effect on 
prognosis of dysfunction in several organ systems. 
Objective probability estimates using continuous variables 
Acute Physiology Score and Chronic Health Evaluation (APACHE)
In  the  mid1970s  William  Knaus  developed  the  APACHE15.  This  score  uses 
continuous variables such as body temperature, serum sodium and pulse rate which are 
likely to be deranged in the setting of critical illness and therefore are more likely to 
portray  an  accurate  image  of  the  severity  of  physiologic  derangement  than  non 
continuous variables. 
However the large number of variables required for the APACHE I became a 
source of systemic inaccuracy. The APACHE I15 presented a practical problem because 
there were 34 variables to be measured and certain variables such as serum osmolality 
and serum lactate  were omitted  more  frequently than the others.  In  this  model  some 
variables deemed important were often not measured, with the problem being confounded 
by  the  model  considering  missing  data  as  normal.  Following  a  multivariate  analysis 
involving each of the apache score variables and mortality it was found that the variables 
considered critical did not improve the overall explanatory power of the system. A major 
criticism of the original APACHE system was that the variables were chosen by a group 
of physicians.  This  panel of experts  approach to selection of variables  introduces the 
potential for bias.
Apache II
The APACHE II4,15 (1985)(Table 4) further reduced the number of variables to 12. 
When  judged  against  the  ideal  predictive  instrument  the  APACHE  II  has  several 
strengths. It had a well defined outcome (Hospital Death); it was derived from a large 
data base, and the source of bias present in its prototype was understood and corrected. It 
takes  into  account  the  age,  pre  morbid  conditions,  and the  principal  reason for  ICU 
admission. It is accurate in predicting overall mortality in critically ill patients and has 
been used widely in clinical trials.
However the APACHE is not free of disadvantages. The scoring occurs within 24 
hours after admission and there is no adjustment for the clinical course.  The important 
sources of error and bias in the APACHE II include a selection bias where inaccuracies 
were  revealed  while  predicting  mortality  in  patients  with  trauma  (due  to  inadequate 
weight  for  Glasgow coma scale),  cardiogenic  pulmonary  edema,  low albumin  states, 
hematological malignancy and hepatic failure. The acute physiologic score does not take 
into account previous treatment and hence may underestimate the mortality of patients 
referred from other hospitals and intensive care units. Another source of error would be 
the reliance on a single diagnosis in the regression equation in calculating the risk of 
mortality. Patients in the ICU often suffer from simultaneous conditions involving more 
than one organ system. Several errors with relation to data collection also plague the 
APACHE II, with the worst values over the first 24 hours of ICU stay being required. 
Considerable inter-observer variability with relation to detail is also a contributing factor.
Apache III
The APACHE III15 draws from a larger and more diverse patient population than 
the APACHE II. The patient’s location prior to ICU admission has been incorporated into 
the scoring to account for lead time bias. A subtle but important difference between the 
two is  that  the  APACHE III  does  not  allow accurate  mortality  prediction  within  the 
disease  specific  group of  patients.  Rather  this  score can  be  used  to  compare  disease 
severity between patients suffering form the same disorder. Even so the presence of a 
selection bias is unavoidable as ICU admission is an arbitrary clinical decision. 
The majority of predictive power derives from weighted continuous physiological 
variables used to calculate a physiology score. When combined with additional points for 
age and significant co morbid conditions a raw score is obtained. The raw score can range 
from 0 to 299 and there is a statistically significant increase in predicted mortality for a 
given diagnosis with each five point increase. New variables such as albumin, bilirubin, 
BUN, blood glucose levels and urine output values were added.  
Recently the APACHE IV16 has been devised to help quantify severity of illness better.
Simplified Acute Physiology Score (SAPS)
The  Simplified  Acute  Physiology  Score15 was  developed  in  response  to  the 
complexity  and the  time  consuming  nature  of  the  APACHE I.  In  this  model  the  34 
variables  that  formed  apart  of  the  APACHE score  were  subjected  to  a  discriminate 
analysis and multiple linear regression test, from which 13 variables were identified as 
having the most discriminate power and were the most frequent ones measured covering 
all  major systems.  Elements of SAPS have been incorporated into subsequent models 
such as the SAPS II (1993). 
The Mortality Prediction Model (MPM)
Separate predictive equations were developed for estimates of mortality risk at the 
time of ICU admission, at 24 hours and after 48 hours of admission15. Eleven clinical 
variables  are  entered.  In  addition  MPM  mortality  predictions  are  not  dependant  on 
admission diagnosis thus eliminating a source of error. All the information required to 
calculate the MPM score is available at the time of ICU admission. Therefore the MPM 
can be used immediately after admission as against the APACHE which has to be done 
24  hours.  However  most  of  the  variables  are  non  continuous  in  nature  and 
misclassification can lead to a large error. The other limitation of the MPM was that its  
data  base  was  initially  drawn  up  from a  single  hospital  raising  the  possibility  of  a 
selection bias.
Glasgow Coma Scale is a score which is still in general use in intensive care. The scale 
avoids  having to describe  a patient's  level  of  neurological  function  in words and the 
assumption that colleagues understand the same meaning from those words. A similar 
scale used in children is shown in table 5.
Scores Specific for Paediatric Intensive Care  
They enable us to investigate the best ways of organizing paediatric intensive care 
(by comparing different units), to monitor the effects of changes in practice (by observing 
trends within units over time), to assess the relationship between severity of illness and 
length-of-stay or cost, and to monitor the effects of rationing intensive care17.    
PRISM, PIM, and PELOD scores are composite scores18 (aggregate scales) that 
are made up of a group of variables. It is the death rate that was used as the outcome 
measure to estimate the validity of all these scores. Many types of variables can be used 
in constructing such scores, including clinical data like heart rate, physiologic data like 
cardiac index, laboratory data like creatinine or PaO2, and other scores like the Glasgow 
coma  score  that  is  integrated  into  the  PRISM score.  The  number  of  points  of  each 
variable are be proportional to its capacity to predict a given outcome. More points are 
attributed to a given variable if the predictive value of the organ or system monitored by 
this variable is more significant. More points are given if the dysfunction is more severe. 
For  example,  in  the  PELOD12  score,  severe  dysfunction  of  the  cardiovascular  or 
neurologic  system is  more  heavily weighted  (up to  20  points)  than  the  renal  system 
(maximum of 10 points).  On the other hand, 20, 10,  1, 0 points can be given in the 
PELOD score for more or less severe dysfunction of the cardiovascular or neurologic 
system. 
Prognostic Scores versus Outcome Scores 
Prognostic  scores  were  developed  to  better  describe  the  severity  of  illness  at 
baseline of groups of critically ill patients. These scores consider some co-morbidities 
and physiologic disturbances at entry into the pediatric intensive care unit (PICU) or at 
randomization  in  a clinical  trial.  They were developed to maximize  prediction  of the 
overall risk of mortality among groups of critically ill patients, given the severity of the 
patients. 
On the other hand outcome scores describe the severity of illness during stay in 
the  intensive  care  unit  (ICU).  In  this  instance,  organ  physiologic  disturbances  are 
collected daily from baseline to outcome or discharge from the ICU. The most abnormal 
values  are  retained.  The  total  of  points  can  be  then  computed  in  risk  of  mortality. 
Outcome scores were developed and validated to maximize description of the clinical 
course of groups of patients. Mean risk of mortality of a population can also be compared 
with actual mortality to get a standardized mortality ratio.
Relevance of composite scores
Discrimination and calibration are two very important characteristics of a score. 
Discrimination is the ability of a test to differentiate patients who meet the outcome (for 
example,  death)  and  those  who  do  not.  The  discrimination  capacity  (predictor 
performance)  of  a  test  is  best  described  by  its  area  under  the  receiver  operating 
characteristics  curve.  The  calibration  of  a  score  is  the  degree  of  correspondence  at 
different  levels  of  probability  between  the  probability  of  the  outcome  (for  example, 
death)  as  predicted  by  the  score  and  the  observed  frequency  of  the  outcome.  The 
statistical  question  is:  are  discrepancies  between  observed  and  expected  mortality 
statistically significant?
Well validated composite scores can be used to harden soft data. Death is a good 
example of hard data:  it  is  easy to get a consensus on its  diagnosis,  and there is  no 
interobserver variability.  For example,  one can use a qualitative scale to describe the 
severity of MODS in PICUs: critically ill children can have no organ dysfunction at all or 
light, moderate, or severe MODS. The problem with such a 4-grade qualitative scale (no 
MODS, light, moderate, or severe MODS) is that the interrater variability is large. Such 
qualitative scale can be considered as soft data because what is meant by words such as  
light, moderate and severe can be very different from one caregiver to the other. There is 
indeed strong evidence that qualitative expressions like that are not reliable. This must 
apply to qualitative scales. 
A semi  quantitative  or  ordinal  score  is  clearly better18.  For  example,  one  can 
describe the severity of cases of MODS by reporting the number of dysfunctional organs, 
which can range from zero to six in critically ill children. There are problems here, too, 
because the risk of death is different from one organ to the other. For example, in a group 
of critically ill patients, neurologic or cardiovascular dysfunctions are more important and 
more predictive of death than hepatic dysfunction. A well developed and well-validated 
quantitative score can take into account the independent weight of each variable that is 
integrated into it. Greater of fewer points are attributed to each variable included in the 
score. 
Composite scores are relevant if they are used. This is the case when  PRISM and 
PIM scores are frequently used to compare the efficacy of different PICUs, given the 
expected mortality predicted by these scores in these units (quality assurance and quality 
assessment),  and  in  clinical  trials  to  compare  the  severity  of  illness  of  patients  at 
randomization.
Subsequently  a  few  important  paediatric  outcome  scoring  systems  will  be 
reviewed  (PELOD,  P-MODS,  DORA, CRIB, SNAP)  followed  by  a  review  of  the 
prognostic scoring systems (PTS, MSSS, PRISM, PIM,). 
Outcome scores
Paediatric Logistic Organ Dysfunction (PELOD)
Multiple organ dysfunction syndrome is more frequent than death in paediatric 
intensive  care  units.  Estimation  of  the  severity  of  this  syndrome  could  be  a  useful 
additional  outcome  measure  in  clinical  trials  in  such units.  The  initial  study12 was  a 
prospective, observational, multi centre cohort study in seven multidisciplinary, tertiary-
care paediatric intensive care units of university-affiliated hospitals (two French, three 
Canadian, and two Swiss) involving 1806 consecutive patients (median age 24 months; 
inter quartile range 5–90). 
PELOD score12 (1999) includes six organ dysfunctions and12 variables and was 
recorded daily.  For  each variable,  the most  abnormal  value  each day and during the 
whole stay were used in calculating the dPELOD (daily PELOD) and PELOD scores, 
respectively. The outcome was vital status at discharge. 
Findings 21% of patients had no organ dysfunction, 26% had one, 25% had two, 
and  28%  had  three  or  more.  Case  fatality  rate  was  6·4%.  The  PELOD  score  was 
significantly higher in non-survivors than survivors (p<0·0001)12.  Calibration of PELOD 
and dPELOD scores was good. Interpretation PELOD and dPELOD scores was found to 
result in valid outcome measures of the severity of multiple organ dysfunction syndrome 
in paediatric intensive care units, and their use could reduce the sample size required to 
complete clinical trials in critically ill children.
Paediatric Multiple Organ Dysfunction Score (P-MODS)
 The  P  MODS29 (2005)  was  developed  in  a  pediatric  intensive  care  unit  at  a 
tertiary care pediatric teaching hospital. A total of 6,456 pediatric consecutive admissions 
(mean age 4.62 yrs) admitted to the pediatric intensive care unit were followed up to 
identify variables that could define organ dysfunction in children and also to develop a 
Multiple Organ Dysfunction Score (P-MODS) while looking for a correlation of the score 
with outcome at pediatric intensive care unit discharge.
Patients were randomly separated into two groups: a development set to create the 
scoring system and a validation set to evaluate score performance and reproducibility. 
Survivors and non survivors were compared to define variables that were significantly 
more abnormal in non survivors. Those variables were correlated with pediatric intensive 
care  unit  mortality  rate.  Optimal  intervals  for  each  variable  were  defined  on  the 
development set, and their performance was evaluated in the validation set. Descriptors 
for organ dysfunction were identified in five organ systems: cardiovascular (lactic acid), 
respiratory (Pa(O(2))/Fi(O(2)) ratio), hepatic (bilirubin), hematological (fibrinogen), and 
renal  (blood urea  nitrogen).  A  grading  scale  for  each  variable  was  set  from 0  to  4, 
corresponding  to  mortality  rates  of  <5%  and  >50%,  respectively.  P-MODS  were 
calculated by summing the worst score for all variables.
 The score correlated strongly and in a graded fashion with pediatric intensive 
care unit mortality rate.  In both sets (development and validation),  mortality rate was 
<5% when the score was 0 and >70% at the highest score. Overall mortality rate was 
5.9%  (development  set)  and  5.3%  (validation  set).  The  score  showed  excellent 
discrimination  reflected  in  areas  under  the  curve:  0.81  (development  set)  and  0.78 
(validation set).
 Dynamic Objective Risk Assessment (DORA)
DORA  (1991)  is  a  mortality  risk  predictor  based  on  physiologic  data  that 
estimates daily the probability of a patient dying within the next 24 hrs as that probability 
changes with disease and recovery. The study was initially done in nine pediatric ICUs. 
Data  from  1,401  patients  (116  deaths,  5,521  days  of  care)  were  used  for  predictor 
development,  and  1,227  patients  (105  deaths,  4,597  days  of  care)  provided  data  for 
predictor validation31.
The predictor was developed by logistic regression analysis using the Paediatric 
Risk of Mortality (PRISM) scores of all previous days as potential predictor variables. 
Performance was measured by the area under the receiver operating characteristic curve 
and by the comparison of the daily predicted vs. observed patient status in five mortality 
risk groups (less than 0.01, 0.01 to 0.05, 0.05 to 0.15, 0.15 to 0.3, greater than 0.3).
 Only the most recent and the admission day Paediatric Risk of Mortality scores 
(with a weighting ratio of 3:1) contributed significantly (p less than .05) to the prediction. 
The daily number and distribution of survivors and non survivors in the five mortality 
risk  groups  were  well  predicted  in  the  total  sample  and  each  ICU  separately.  This 
dynamic predictor improved (p less than .01) ICU outcome prediction over an admission-
day predictor31.
The predictor was previously considered valid for assessing the 24-hr mortality 
risk in pediatric ICU patients hospitalized in other tertiary care institutions, different from 
those used for predictor  development.  The predicted mortality risks allow prospective 
patient stratification into risk groups. The ability of this predictor to follow risk changes 
over time expanded its applicability over static  predictors by enabling the charting of 
patient courses, and permitting ICU efficiency analysis
Clinical Risk Index for Babies (CRIB I and II)
CRIB (Table 6) is a neonatal scoring system. Scores are given for birth weight, 
gestational age, maximum and minimum fraction of inspired oxygen and maximum base 
excess  during  the  first  12  h,  and  presence  of  congenital  malformations11.  CRIB was 
developed retrospectively in a cohort of 812 infants of birth weight 1500 g or less or 
gestational age less than 31 weeks treated in four UK tertiary hospitals between 1988 and 
1990. The area under the receiver operating characteristic (ROC) curve for predicting 
death in this validation cohort (a measure of the predictor's accuracy) was significantly 
greater for CRIB than for birth weight alone (0·90 [SE 0·05] vs 0·78 [0·03], P=0·03). 
Calculation  of risk- adjusted mortality  by means  of  CRIB showed that  babies 
were twice as likely to die in the non-tertiary hospitals as in the tertiary hospitals in the 
UK (odds ratio 2·12 [95% CI 1·39-3·24]). Adjustment for birth weight alone also showed 
higher odds of death in non-tertiary hospitals (1·45 [1·01-2·11]). CRIB was considered a 
robust index of initial neonatal risk that is more accurate than birth weight and simple 
enough for routine use.
The  appropriateness  of  CRIB  with  contemporary  data  was  subsequently 
questioned,  that  it  might  be no better  in  prediction  of  mortality  than  birth  weight  or 
gestation alone. Furthermore, CRIB included fraction of inspired oxygen (FiO2), which is 
not  a true physiological  measure  because it  is  determined by the care  team and also 
includes data up to 12 h after admission, thus potentially introducing early treatment bias. 
Therefore a new five-item CRIB II score32 was developed with data from a UK-
wide  sample  of  1886  infants  admitted  in  1998–99.  CRIB  II  avoided  the  potential 
problems  of  early  treatment  bias.  CRIB II  developed  and assessed  for  infants  of  32 
weeks’  gestation,  with  further  data  available  up  to  1  h  after  admission  to  neonatal 
intensive care, excluding FiO2. 
Simplified Newborn Illness Severity and Mortality Risk Scores 
(SNAP, SNAP-II and SNAPPE-II)
Substantial variation in birth weight-adjusted mortality among neonates reflects 
differences in  population  illness  severity.  The  Score for  Neonatal  Acute  Physiology33 
(SNAP) was developed in 1992 and validated prospectively on 1643 admissions (114 
deaths) in three ICUs. SNAP scored the worst physiologic derangements in each organ 
system in the first 24 hours. SNAP showed little correlation  with birth weight and was 
highly predictive of neonatal  mortality even within narrow birth  weight  strata.  It  was 
capable of separating patients into groups with 2 to 20 times higher mortality risk. It also 
correlated highly with other indicators of severity including nursing workload (r = .59), 
physician estimates of mortality risk (r = .65), and length of stay (R2 = .59). 
Subsequently a  Simplified  Neonatal  Illness  Severity  and Mortality  Risk Score 
(Table 7) (SNAP-II and SNAPPE-II)  was developed in thirty neonatal  intensive  care 
units  in  Canada,  California,  and  New  England  during  the  mid  1990s.  SNAP-II  and 
SNAPPE-II  are  empirically  validated  illness  severity  and  mortality  risk  scores  for 
newborn34.
The primary  outcome was  in-hospital  mortality.  Patients  moribund  at  birth  or 
discharged to normal newborn care in <24 hours were excluded. Starting with the 34 data 
elements of the Score for Neonatal Acute Physiology (SNAP), a logistic model for in-
hospital mortality was designed using 10,819 randomly selected Canadian cases. SNAP-
II includes 6 physiologic items; to this were added points for birth weight, low Apgar 
score,  and  small  for  gestational  age  to  create  a  9-item  SNAP-Perinatal  Extension-II 
(SNAPPE-II). SNAPPE-II was validated on the remaining 14,610 cases and optimized 
the calibration. 
The discrimination of deaths from survivors by SNAPPE-II was excellent34, with 
ROC areas ranging from 0.84 to 0.92 in the various populations and subgroups, with an 
overall performance of .91 ± 0.01, the weakest performance being for infants with birth 
weights  <1500  g.  For  comparison,  ROC  areas  for  birth  weight  alone  were  .78  ± 
0.01overall,  .78  ±  0.01  for  infants  <1500  g,  and  .51  ±  0.02  for  infants  >1500  g. 
Combining only birth weight, SGA, and low Apgar score (without SNAPII) showed ROC 
areas of .84, .81, and.76 for the 3 birth weight groups, respectively.  The substantially 
higher discrimination by SNAPPE-II indicated the value of the additional physiologic 
derangement information. 
Prognostic (predictive) scores
Paediatric Trauma Score (PTS)
The  Pediatric  Trauma  Score  (Table  8)  is  a  trauma  scoring  tool  for  use  in 
evaluating the severity of injury. The PTS35 adjusts its scoring areas to account for the 
physiological  and anatomical  differences  unique to  the pediatric  patient  in  turn more 
accurately identifying the critical patient. The PTS also allows for data gathering efforts 
which  will  be  especially  important  with  the  development  of  a  country  wide  trauma 
system and trauma registry.  Locally the PTS can provide data on injury patterns for a 
geographical  location  which  can  be  used  to  develop  injury  prevention  programs  and 
continuing education programs for EMS personnel.
The  PTS  consists  of  six  parameters  which  are  common  determinants  of  the 
clinical condition in the injured child. During the initial assessment of the injured child 
each parameter is assessed and given a numeric score based upon its three associated 
variables:  +2 (no  injury  or  non-life  threatening),  +1  (minor  injury or  potentially  life 
threatening), or -1 (life-threatening). Totals can range from a +12 to a -6 with the range of 
<8-9 being the critical break point for transport to a comprehensive pediatric trauma care 
facility.
Critically  ill  patients  are  typically  characterized  by  disturbances  of  body 
homeostasis.  Both  in  adults  and  children,  these  disturbances  can  be  estimated  by 
measuring  how apart  one  or  many physiologic  variables  are  from the  normal  range. 
Composite scores are constructed with such variables. 
Meningococcal Septic Shock Score MSSS
A  sensitive  scoring  method  for  identification  of  children  with  presumed 
meningococcal  septic  shock  (PMSS)  (Table  9)  at  risk  of  death  at  admission  to  the 
pediatric intensive care unit was developed in 200138.The investigators wanted to develop 
a  mortality  prediction  tool  for  PMSS and  compare  its  performance  with  three  other 
prognostic  systems:  1)  a  generic  mortality  prediction  tool,  the  Pediatric  Index  of 
Mortality (PIM), 2) the Glasgow Meningococcal Septicemia Prognostic Score (GMSPS) 
and 3) the Malley score. The study design was a multi-center retrospective cohort 
The  study  involved  all  children  aged  between  1  month  and  14  years  with  a 
confirmed or presumed diagnosis of meningococcal septic shock admitted to 14 PICU's 
of tertiary level hospitals in Spain. 
The worst value of each variable during the first 2 hours in the PICU was selected 
for the analysis. 30 prognostic variables were tested: (demographic and clinical)39. Also 
included  were  2  therapeutic  variables:  use  of  mechanical  ventilation  and  refractory 
hypotension. The use of steroids as a predictor was not evaluated. The logistic regression 
identified seven independent predictors of death at admission: cyanosis, coma (GCS < 8), 
refractory hypotension, oliguria, WBC < 4000/mm3, PTT > 150% of control and base 
excess > -10mmol/l. 
The primary outcome measure was hospital mortality, defined as death occurring 
before hospital discharge. A higher score on the model predicted a higher probability of 
death.  The  other  three  scores  yielded  lower  ROC  areas  and  this  was  statistically 
significant for the differences between the new score and the Malley and GMSPS ROC 
curves. 
The 95% confidence intervals for the estimates of risk of death are not stated in 
the article.  However,  by converting the % mortality estimate in the three groups into 
proportions and using the raw numbers given in the article it is possible to calculate the 
95% CI. Of note, the confidence intervals in the three risk groups do not overlap. 
However, the new ICUs were still within the same geographic locale (Spain) and 
hence  share  important  population  characteristics.  The  prediction  tool  may  work 
differently in a different population, e.g., USA, and so it is important to validate a tool in 
several  different  clinical  settings  especially  if  the  probabilities  of  death  are different. 
Ideally, a validation of the cutoff values of the predictor variables (the prediction model) 
should be a) prospective and b) in a new population and c) with a different prevalence 
and spectrum of the underlying disease. The current study does not meet the first criterion 
as it was retrospective but does meet the second criterion fully. It meets the third criterion 
partially as the validation sample had an overall different case mix and study period than 
the development sample. Specifically, there were significantly more cases of sero group 
C, female sex and a shorter time to admission to the PICU from the time of appearance of 
petechiae. 
The new score differs from a generic prediction tool like the  PRISM and PRISM 
II  in  that  it  is  derived  from  a  more  homogenous  group  of  patients  ("customized 
probability model").  Neither the new scoring system nor the comparison models were 
able to predict a risk group with 100% mortality. Information from the model about the 
child's average risk of dying, may be useful to surrogate decision makers like parents and 
to  treating  clinicians  in  making  informed  decisions  about  the  risks/benefits  of 
aggressive/expensive therapies. 
Paediatric risk of mortality score (PRISM)
The  Paediatric  Risk  of  Mortality18 (PRISM)  score  was  developed  from  the 
Physiologic Stability Index (1986)21  by Pollack et al.  (it  is named PRISM II score by 
some intensivists) to reduce the number of physiologic variables required for pediatric 
ICU  (PICU)  mortality  risk  assessment  and  to  obtain  an  objective  weighting  of  the 
remaining variables.  Univariate  and multivariate  statistical  techniques were applied to 
admission  day PSI  data  (1,415 patients,  116 deaths)  from four  PICUs in the  United 
States.  The  resulting  PRISM  score  consisted  of  14  routinely  measured,  physiologic 
variables, and 23 variable ranges. The performance of a logistic function estimating PICU 
mortality risk from the PRISM score, age, and operative status was  tested in a different  
sample  from  six  PICUs  (1,227  patients,  105  deaths),  each  PICU  separately,  and  in 
diagnostic  groups  using  chi-square  goodness-of-fit  tests  and  receiver  operating 
characteristic (ROC) analysis. In all groups, the number and distribution of survivors and 
non survivors in adjacent mortality risk intervals were accurately predicted. ROC analysis 
also demonstrated excellent predictor performance (area index = 0.92 +/- 0.02).
PRISM is accurate and widely accepted, but many units do not use it routinely 
because it is difficult to collect the large amount of information needed to calculate it. 
PRISM scores should be used in critically ill neonates, infants, children, or adolescents, 
not in premature infants or in adults The variables used by PRISM that are not used by 
PIM are diastolic blood pressure, heart rate, respiratory rate, arterial partial pressure of 
carbon  dioxide,  the  Glasgow Coma  Score  prothrombin  time,  serum bilirubin,  serum 
potassium, serum calcium, blood glucose and plasma bicarbonate. 
Updated Paediatric Risk of Mortality score (PRISM III)
             The relationship between physiologic status and mortality risk was reevaluated as 
new  treatment  protocols,  therapeutic  interventions,  and  monitoring  strategies  are 
introduced, and as patient populations changed necessitated the development of a third-
generation  pediatric  physiology-based  score.  In  addition,  since  minimizing  the  time 
period for assessing mortality risk is advantageous for evaluating pediatric ICU quality, a 
12-hr prediction model as well as a 24-hr prediction model was developed. The PRISM 
III  was developed  in  32 pediatric  intensive  care  units  representing  about  10% of  all 
pediatric ICUs in the United States20, between 1993 and 1994. Consecutive admissions at 
each site were included until at least 11 deaths per site occurred. 
Exclusion criteria included a) admissions for recovery from procedures normally 
cared for in other hospital locations; b) patients staying in the ICU less than 2 hrs; c) 
patients transferred from the study pediatric ICU to another ICU because their outcome 
could  not  be  clearly  credited  to  either  ICU;  and  d)  patients  admitted  in  a  state  of 
continuous cardiopulmonary resuscitation who never achieved stable vital  signs for at 
least 2 hrs.
An attempt was made at maximizing the predictive performance while keeping 
the number of variables and their ranges to a minimum, using variables that are readily 
available  and  clearly  definable  while  maintaining  the  assumptions  inherent  in  the 
Physiologic Stability Index and PRISM that unmeasured variables were assumed to be 
normal. Therapeutic variables that may be unduly influenced by practice patterns were 
avoided.
Physiologic data included the most  abnormal  values from the first  12 and the 
second  12  hrs  of  ICU  stay.  Outcomes  and  descriptive  data  were  also  collected. 
Physiologic variables in which normal values change with age, were stratified by age 
(neonate,  infant,  child,  adolescent).  The data  consisted  of  the  following:  systolic  and 
diastolic blood pressures; heart rate; respiratory rate; temperature (oral, axillary, or core); 
coma status; pupillary reactions; pupillary size and equality; concentrations of sodium, 
potassium, total CO2, bicarbonate, total and direct bilirubin, total and ionized calcium, 
glucose,  blood  urea  nitrogen,  creatinine,  and  albumin;  hemoglobin;  white  blood  cell 
count;  platelet  count;  prothrombin  and  partial  thromboplastin  times;  pH  and  PCO2 
(arterial, venous, or capillary); and PaO2 with a simultaneous FIO2. Whole blood as well 
as serum/plasma measurements of sodium, potassium, and glucose were also collected. 
For variables where both high and low abnormalities may reflect increased mortality risk, 
both the high and the low values were collected. Thus, both high and low values of the 
same  physiologic  variable  could  contribute  to  severity  of  illness.  Physiologic  data 
accumulated during the pre terminal period in patients dying within the first 24 hrs of 
pediatric ICU care were not included in the study when death was obvious. 
When several variables overlapped significantly in the assessment of physiologic 
dysfunction, they were combined into a composite variable. For example, pH and total 
CO2   were combined into a variable representing acidosis.
The database was randomly split into development (90%) and validation (10%) 
sets. Variables and their ranges were chosen by computing the risk of death (odds ratios) 
relative to the midrange of survivors for each physiologic variable. Data were collected 
on 11,165 admissions (543 deaths). The PRISM III score has 17 physiologic variables 
subdivided into 26 ranges. The variables  most  predictive of mortality were minimum 
systolic blood pressure, abnormal pupillary reflexes, and stupor/coma. Other risk factors, 
including two acute and two chronic diagnoses, and four additional risk factors, were 
used in the final predictors. Variables in the original PRISM that are not included in 
PRISM III are diastolic blood pressure, respiratory rate, PaO2 /FIO2, and bilirubin and 
calcium concentrations20. Variables which are included in PRISM III but not in PRISM 
are temperature, pH, PaO2, creatinine concentration, blood urea nitrogen concentration, 
white blood cell count, and platelet count.
The PRISM III score and the additional risk factors were applied to the first 12 
hrs of stay (PRISM III-12) and the first 24 hrs of stay (PRISM III-24). There were no 
significant calibration errors. The area under the receiver operating curve and Flora's z-
statistic  indicated  excellent  discrimination  and  accuracy  (area  under  the  receiver 
operating curve for PRISM III-12 (.947 +/- 0.007); PRISM III-24 (0.958 +/- 0.006). 
Generally,  the PRISM III-24 performed better  than the PRISM III-12 models. 
Excellent  goodness-of-fit  was also found for  patient  groups stratified  by age,  and by 
diagnosis. PRISM III-24 was compared with the original PRISM, area under the receiver 
operating curve improved by 3.9% (PRISM 0.914; PRISM III 0.950, p less than .0001). 
PRISM  III  resulted  in  several  improvements  over  the  original  PRISM. 
Reassessment of physiologic variables and their ranges, better age adjustment for selected 
variables, and additional risk factors resulted in a mortality risk model that was more 
accurate and discriminates better.  First, the physiologic variables and their ranges were 
reevaluated  thereby  eliminating  some  ranges  that  did  not  contribute  significantly  to 
mortality risk (e.g., high systolic blood pressure). Although some physiologic variables 
have been eliminated  and others  added the  variables  with  the  greatest  importance  in 
outcome prediction were the same in both scores: low systolic blood pressure, altered 
mental status, and abnormal pupillary reflexes.
While age was included as an explicit variable in the original PRISM score, it was 
included in the PRISM III score in a logically and clinically more convincing form by 
using appropriate age-adjusted physiologic variable ranges. 
The  relationship  between  physiologic  status,  as  measured  by PRISM III,  and 
outcomes has been calibrated to a contemporary,  diverse, well-defined, large reference 
sample.. These units encompass a wide diversity of organizational structure and patient 
mixes.  This  diversity  makes  the  sample  sufficiently  representative  for  most  units, 
enabling PRISM III to be used in the comparative assessment of pediatric ICU outcomes 
in essentially all pediatric ICUs.
PRISM reduced the number of physiologic variables to 14 and their ranges to 34. 
The total number of ranges in PRISM III was reduced. PRISM III-24 incorporates the 
most information over the longest time period.  The use of the PRISM III-12 model is  
appealing  for quality  assessments  since,  by shortening data acquisition  time,  it  better 
separates the observation from the treatment period, while the PRISM III-24 model is 
more  accurate  for  individual  patient  mortality  risk assessments.  The large  number  of 
diverse ICUs in the database indicates PRISM III was more likely to be representative of 
United States units. A serious problem with 12 or 24-h scores was that they were affected 
by treatment given after admission to intensive care, so that they are not valid instruments 
for comparing the quality of care between different units, or within a single unit over 
time. Children admitted to a good PICU who recovered were found to have lower PRISM 
scores than similar Children admitted to a bad PICU who are mismanaged in the first12–
24 h, and the bad unit‘s high mortality rate will be incorrectly attributed to its having 
sicker patients. 
Development of the Paediatric index of mortality scores (PIM and PIM2)
Paediatric index of mortality (PIM)
Towards the end of the 20th century a need was felt for models that predict the risk 
of  mortality  in  children  in  intensive  care  which  would  allow  evaluation  of  the 
effectiveness and efficiency of paediatric intensive care. Models to compare the standard 
of care between units and within units over time by adjusting for differences in severity 
of  illness  and  diagnosis  were  required.  Comparing  different  systems  of  organising 
intensive  care  was  another  need  at  that  point.  Estimating  mortality  risk  was  also 
considered an important component of comparing groups of patients in research trials. 
One such score was the PIM score. 
The initial score was developed using three prospective cohort studies from the 
year 1988 to 199522. A fourth cohort study, from 1994 to 1996, collected information 
from consecutive admissions to seven paediatric intensive care units in Australia and one 
in  Britain.  The development  of  PIM began in 1988,  when information  was collected 
about 678 consecutive admissions over 6 months to the PICU at the Royal Children‘s 
Hospital,  Melbourne.  The variables  collected  were the 34 PSI (physiological  stability 
index) variables21, along with mean arterial pressure, ventilator peak inspiratory pressure 
(PIP),  ventilator  positive  end-expiratory  pressure  (PEEP),  motor  response  to  pain, 
immature neutrophil count, total neutrophil count, base excess, and rectal temperature. 
The worst value of each variable in the first 24 hours after admission as recorded for all 
678 patients, and the admission values were also recorded for the last 230 patients. 
The second stage22 of the study began in 1990, when 814 consecutive admissions 
to a PICU at Melbourne were studied. Information was collected at the time of admission 
and over the first 24 h in PICU about age, gestational age, pupil reaction to light, and 
motor response to pain, base excess, mean arterial pressure, and respiratory rate, arterial 
carbon dioxide tension (PaCO2), PIP and PEEP. 
In  the  third  stage22 of  the  study,  from  February  1994  to  March  1995,  1412 
consecutive  admissions  to  the  PICU  at  Melbourne  were  studied.  Information  was 
collected at the time of admission to PICU and during the first 24 h about all PRISM 
variables plus information about sex, time in hospital before admission to PICU, need for 
mechanical ventilation, diagnosis, the presence of a right-to-left cardiac shunt, estimated 
fractional  inspired oxygen concentration (FIO2) in unintubated patients,  weight, mean 
blood pressure, each pupil‘s size and reaction to light, PIP, PEEP, PaCO2, base excess, 
and plasma sodium. The above parameters were then evaluated for an association with 
mortality.  The continuous  variables  were appropriately transformed  and tested  for  an 
association  with  mortality.  With  the  exception  of  age  and  time  in  hospital  before 
admission to intensive care (lead time), variables that were not associated with mortality 
on Univariate testing (p>0.1) were excluded from further analysis. A preliminary model 
was  developed.  In  the  fourth  stage  of  the  study,  during  the  period  1994–1996, 
information  about  the  variables  in  the  preliminary  model  (plus  plasma  sodium  and 
prothrombin time) was collected from consecutive admissions less than 16 years of age to 
four PICUs in Australia (the learning sample) and one PICU in Britain and three PICUs 
in  Australia  (the  test  sample).  Each  unit  collected  data  from  enough  consecutive 
admissions to include at least 20 deaths. As a check on the accuracy of data collection, a 
sample of the data was collected in duplicate. The information from the above was used 
as a learning sample to determine the regression coefficients of a logistic model. The fit 
of the model developed on the learning sample was then tested on children admitted to 
the PICUs at Birmingham, Brisbane, and Adelaide. Calibration of the model, to evaluate 
how well the model classifies subjects into low, medium and high risk categories, was 
done. Inspection of the number of observed and expected deaths and survivors in five 
groups with <1%, 1–4%, 5–14%, 15–29% and 30% or more predicted mortality was also 
carried out. Discrimination estimates how well the model distinguishes between patients 
who lived and patients who died. Once the model was found fit in both the development 
and the validation groups,  logistic  regression coefficients  were re-estimated using the 
entire sample. The first, second and third parts of the study were used to determine the 
variables that were included in the fourth part of the study. A total of 5695 children were 
in the fourth part of the study, and 278 of them died. Six of the 278 deaths occurred 
within 24 h of discharge from intensive care. No patient was lost to follow-up22.
Physiological  variables that  were not measured were considered to be normal. 
Values  for  systolic  blood  pressure,  base  excess  were  transformed  using  statistical 
methods24,25. The predictive power of pupil size, inequality in size, and their reaction to 
light was obtained.
Each child was allocated one of 214 different  diagnoses; nine diagnoses were 
associated with an increased risk of mortality, even when information from the other PIM 
variables was taken into account. 
Prediction was not improved by having a different coefficient for each of the nine 
diagnoses, by the inclusion of interaction terms in the model, or by including the square 
of the transformed base excess variable, the square of FIO2/PaO2, or the logarithm of 
transformed  systolic  blood pressure.  Variables  that  did  not  predict  death  were serum 
bilirubin, pulse rate, central venous pressure, haemoglobin, the presence of convulsions, 
left atrial pressure, and days in hospital before admission to intensive care (the lead time). 
Variables such as the prothrombin time and the serum sodium value were statistically 
significant  when added to the final  model,  but  were excluded because they had little 
effect on the fit of the model. So the final parameters as chosen by the PIM score were 
Pupils  fixed to  light,  Specified diagnosis,  Elective  admission,  Mechanical  ventilation, 
absolute (SBP-120) mmHg, absolute (base excess), 100´FiO2/PaO2 (mmHg–1). 
Some of the other salient findings of the study to device the PIM score include the 
fact that neonates had a higher mortality than older children, but inclusion of age did not 
improve the prediction of the model. Correction for age did not improve the predictive 
power of systolic or mean blood pressure, pulse rate, or respiratory rate.  None of the 
PICUs  had  a  significant  effect  when  they  were  included  in  the  model  as  dummy 
variables. 
The final model was estimated using the entire sample from the fourth part of the 
study. The deciles of risk goodness-of-fit test gave p=0.37 and the areas under the ROC 
plot  was  found  to  be  consistently  above  0.8022.  The  model  described  their  risk  of 
mortality for babies less than one month well. A training model was developed on one 
group of intensive care units and was applied to another group of unit so as to provide a 
more stringent test than just randomizing individual patients to the training or test set26. 
Death was chosen as the dependent variable in this model, rather than death in 
hospital  or death within one month of admission into a  PICU. Death in PICU is the 
mortality outcome that is of most practical interest to paediatric intensivists and was the 
outcome used by PRISM17. Multiple admissions for an individual were included in the 
study because the model was used on data that includes children who are admitted several 
times. 
Mortality prediction models, such as the PIM are developed by finding variables 
that predict the probability of death in groups of children. This model is then often used 
as a measure of severity of illness, which assumes that children with a high risk of death 
are sicker than children with a low risk of death. This assumption may be true for many 
types of PICU patients, but not all. An example quoted by the authors of the PIM include 
children with epiglottitis or severe croup are very likely to die without intensive care, but 
they have a very low mortality if they are properly managed – so the PIM would give 
these children a low score despite the fact that they are very ill. Although the PIM may 
provide a fairly good description of groups of patients, it may not be accurate enough to 
be used to make decisions about the management of individual patients.
The PIM model was simple enough for it to be widely used in paediatric intensive 
care  –  it  required  the  collection  of  only  eight  variables  at  the  time  of  admission  to 
intensive  care,  while  having  a  good  predictive  power.  The  PIM  was  developed  in 
dedicated PICUs where there are high levels of consultant input, senior resident staff and 
trained PICU nurses. 
Paediatric index of mortality 2 score (PIM2)
Outcome  in  terms  of  mortality  is  influenced  by  new  treatments  and  new 
management approaches. Changes in referral practices,  systems of providing intensive 
care, attitudes to the indications for commencing and discontinuing life support lead to 
changes in thresholds for admission to intensive care and alterations in the relationship 
between disease and outcome. Further, as experience, and therefore the quantity of data, 
expands it  is possible  to use a larger and more diverse patient  population to develop 
mortality prediction models.
The objective behind development of the PIM227 (Table 10) was to revise the 
Paediatric  Index  of  Mortality  (PIM)  to  adjust  for  improvement  in  the  outcome  of 
paediatric intensive care, through an international multi centre observational study carried 
out  in  twelve  specialist  paediatric  intensive  care  units  and  two  combined  adult  and 
paediatric  units  in  Australia,  New Zealand  and  the  United  Kingdom.  20,787  patient 
admissions  of  children,  less  than  16  years,  admitted  during  the  study  period  were 
included.  Again  there  were  no  interventions27.  A  revised  model  was  developed  by 
forward and backward logistic regression. Variable selection was based on the effect of 
including or dropping variables on discrimination and fit. The addition of three variables, 
all derived from the main reason for ICU admission, improved the fit across diagnostic 
groups. Data from seven units were used to derive a learning model that was tested using 
data  from  seven  other  units.  The  model  fitted  the  test  data  well  and  discriminated 
between death and survival well (area under the receiver operating characteristic (ROC) 
plot 0.90 (0.89-0.92)). The final PIM2 model, derived from the entire sample of 19,638 
survivors  and  1,104  children  who  died,  also  fitted  and  discriminated  well  [2  11.56, 
p=0.17; area 0.90 (0.890.91)27. 
Ten  Australian  and  New  Zealand  intensive  care  units,  and  4  British  units28 
collected uniform paediatric data commencing on January 1, 1997. The data included the 
PIM variables, demographic variables, the principal ICU diagnosis (defined as the main 
reason for ICU admission) and ICU outcome (died in ICU, discharged or transferred to 
another ICU).  Data from the above were combined to develop and validate a revised 
model,  PIM2.  All  patients  admitted  consecutively  during  the  period  of  study  were 
included. Patients 16 years or older were excluded, as were patients transferred to other 
ICUs, because these patients could not be appropriately classified as ICU survivors or 
deaths.  
The first step in revising the model was to examine the ratio of observed deaths to 
deaths predicted by PIM in the entire population, and when patients were grouped by 
mortality risk, diagnosis, diagnostic group, intensive care unit, and age27. The aim was to 
identify patient  groups where PIM either  over-predicted  or  under-predicted  mortality. 
Individual  variables  were  examined  for  association  with  mortality  using  appropriate 
statistical  methods.  When  appropriate,  transformation  was  used  to  improve  the 
relationship between a variable and mortality, followed by forward and backward logistic 
regression to  test  each  of  the  original  variables  and potential  additional  or  substitute 
variables.
To test the revised model,  the population was divided into a learning and test 
sample by randomly selecting units, stratified by size of unit and country. The logistic 
regression model developed in the learning sample was evaluated in the test sample by 
calculating  the  area  under  the  receiver  operating  characteristic  plot  to  assess 
discrimination  between  death  and  survival29.  Calibration  across  deciles  of  risk  was 
evaluated using the Hosmer-Lemeshow goodness-of-fit test.  To examine the fit  of the 
model in more detail, tables were constructed to assess calibration across risk, age, and 
diagnostic group by visual inspection of the number of observed and expected deaths. 
The reproducibility of data collection in each unit in was assessed by repeating 
the data collection for 50 randomly selected patients stratified by mortality risk. Data 
quality was assessed by comparing the probability of death predicted by PIM in the two 
data sets. The results of this study revealed 1,104 deaths, giving a mortality rate of 5.3%. 
Logistic regression was used to generate new coefficients for the original PIM variables. 
This re-calibrated, first generation model was then tested. Discrimination was adequate 
(area under the curve in a ROC was 0.88 (CI 0.87-0.89))27, however, calibration across 
diagnostic  groups  was  poor  in  two  groups:  respiratory  illness  and  non-cardiac  post-
operative patients (observed: expected deaths, 160:212.8 and 48:82.0, respectively). The 
PIM variable "Specific Diagnosis" included nine diagnoses associated with increased risk 
of death. The diagnoses –in hospital cardiac arrest and liver failure were associated with 
increased  risk  of  death  and  five  common  diagnoses  (asthma,  Bronchiolitis,  croup, 
obstructive sleep apnoea, diabetic keto-acidosis) were associated with reduced risk. The 
mortality  of  patients  admitted  primarily  for  post-operative  recovery  was  better  than 
predicted by PIM for all surgical groups except for patients admitted following cardiac 
bypass. "Specific Diagnosis" seen in the PIM was replaced by "High Risk Diagnosis" and 
"Low Risk Diagnosis" in the PIM 2. Pupillary reactions as defined in PIM remained a 
significant predictor both in Univariate and multivariate analysis. No change was made to 
the four physiological variables from the original model. 
In the test sample the new model discriminated well between death and survival 
[Area under the curve (Az) ROC 0.90 (0.89-0.92)] and calibrated across deciles of risk 
well (goodness of fit 2 8.14, 8df, p=0.42). The final PIM2 model estimated from the entire 
sample also discriminated and calibrated well (Az ROC 0.90 (0.890.91); goodness-of-fit 
test 2  11.56, 8df, p=0.17)27. The performance in respiratory illness and non-cardiac post-
operative patients was improved in the revised model. 
PIM2 was derived from a larger, more recent and more diverse data set than the 
one used for the first version of PIM27. Three variables, all derived from the main reason 
for ICU admission, had been added to the model (admitted for recovery from surgery or a 
procedure,  admitted  following  cardiac  bypass  and low risk diagnosis).  Changes  have 
been made  to  the  variable  "High Risk  Diagnosis":  the  criteria  for  cardiac  arrest  had 
changed, liver failure was been included and IQ below 35 omitted. 
On application  of  the  original  PIM model  to  the  second data  set,  the  overall 
standardized mortality ratio (SMR) was 0.86 (0.81-0.90) with similar values encountered 
in all units. However 14% of the children predicted to die using 1994-1995 standards 
survived in 1997-199927. The explanation for this improvement was not known. It was 
considered that that incremental gain had been achieved by improved application of old 
therapies. Critically ill children were probably being recognized and referred earlier with 
good effect. It was not possible to test these or other hypotheses on the current data and 
the explanation for the apparent improvement in management is unknown. The standard 
of care set by the original PIM was high22 compared to PRISM and PRISMIII with the 
standard set by PIM2 is even higher27. 
The same methods were used in the development of both models. Variables were 
included only if they improved the discrimination or calibration of the model. To test the 
new model,  the data were split  into two groups of units.  Coefficients  derived on the 
learning  sample  demonstrated  good  performance  in  the  test  sample.  The  coefficients 
derived from the entire sample were used in the final model.
As  well  as  calibrating  across  mortality  risk,  it  was  considered  important  that 
intensive care prediction models  calibrate  across diagnostic  groups.  If  the model  was 
found to over- or under-predict mortality in a large group of patients, then the overall 
performance of the unit assessed by the model would be influenced by the proportion of 
patients admitted in this category. This was found to result in biasing the estimated SMR 
but also exposed the added danger that units would dismiss potentially important results 
because  they  attribute  an  unexpected  finding  to  the  mix  of  patients  rather  than  the 
standard  of  care.  The  first  version  of  PIM  over-predicts  death  in  non-cardiac  post-
operative patients and, to a lesser extent, respiratory patients. This trend was evident in 
the original study; however, although there were more than 5000 patients in that study, 
there were only six deaths in non-cardiac post-operative patients. In the study to develop 
PIM 2 there were 48 deaths in this diagnostic group and the tendency for the original PIM 
to over-predict death was confirmed. The addition of variables that identify diagnoses 
with a low risk of mortality has improved the performance of PIM2 in non-cardiac post-
operative patients and respiratory patients. The diagnoses included in the variables "High 
Risk Diagnosis" and "Low Risk Diagnosis" represent conditions where the physiological 
and demographic PIM2 variables either under-estimate or over-estimate the risk of death. 
Diagnoses  associated  with  high  or  low  risk  of  death  where  the  risk  was  accurately 
predicted by the physiological and demographic PIM2 variables were not included in the 
specific high or low risk diagnoses. 
Examination  of  the model  performance in  specific  diagnoses resulted  in  other 
changes  to  the  model.  The  risk-adjusted  outcome  for  cardiac  arrest  preceding  ICU 
admission was similar for in-hospital and out-of-hospital cardiac arrest; therefore PIM2 
does not restrict cardiac arrest preceding ICU admission to out-of-hospital cardiac arrest. 
Liver failure (acute or chronic) as the main reason for ICU admission has been added to 
the  list  of  high  risk  diagnoses.  The  specific  diagnosis  "IQ  below 35"  was  removed, 
primarily because it proved difficult to code reproducibly, particularly in young children. 
Omitting this diagnosis from the model altered the area under the ROC plot by less than 
0.1%27.  A major advantage of using admission data to estimate the mortality risk was 
that the model was not biased by the quality of treatment after admission. In this respect 
PIM  is  preferred  to  models  that  use  data  collected  during  the  first  12-24 h  after 
admission.  A  potential  criticism  of  PIM,  however,  was  that  one  of  the  variables, 
mechanical ventilation during the first hour, was also susceptible to bias resulting from 
different intervention thresholds. In the PIM2 study the percentage of patients intubated 
during their ICU stay varied between units from 25 to 93%. 
Mechanical ventilation during the first hour could be considered a simple way of 
accounting for variation in admission thresholds and weighting the model for patients that 
require life  support.  Ideally,  mortality  prediction  models  should not be influenced by 
treatment. Omission of the ventilation variable from the model, resulted in a drop in the 
the area under the ROC plot from 0.90 to 0.8827. 
Accurate data collection is critically important. There is an increase in complexity 
with the number of variables  in the model  increased from seven to ten in PIM2, the 
additional  variables  being  derived  from  the  principal  ICU  diagnosis,  which  is  an 
important variable for all ICU patients. When data is collected as given in the PIM 2 
guidelines rather than deriving these codes electronically from a database containing the 
diagnosis, it allows a consistency of coding and also enables electronic checking against 
the diagnosis to be used as a technique to verify the data. It was thought not advisable for 
data to be collected by large numbers of doctors and nurses as an addendum to their  
routine clinical work. In this study, the 95% confidence intervals for the bias in risk of 
death estimation included 1.0, suggesting that data collection errors were not significantly 
affecting prediction. 
When the score did not predict the correct  number of deaths in a unit,  it  was 
considered that the standard of care respective unit was better or worse than the standard 
in the units that developed PIM2 in 1997-1999, or that the characteristics or diagnoses of 
patients in the unit were substantially different from the population in the original study. 
Changing the coefficients in the model to ensure better outcome prediction defeats one of 
the main purposes of the model, which is to allow units to compare their performance 
with that of the Australasian and UK units that developed it. PIM2 was applied only to 
groups of patients and not allowed to describe or influence the management of individual 
patients. 
Details on instructions for use of the PIM2 score are given in appendix 1.
Results of various studies world wide using the PIM are discussed in the tables 11 
and 12. 
Differences between the PIM and the PRISM
Shann et al22 developed the PIM score as an alternative to the PRISM III  20  for 
comparing observed with predicted mortality among PICUs. Any score should be valid, 
reliable, accurate, easier to use and cost-effective. Whether mortality prediction scores 
are a valid measure of the quality-of-care delivered by a PICU, is an important question. 
The PIM has a simple job to do: to predict death for patients who die and survival 
for those who live. The evaluation of the ability of a score to discriminate among these 
two populations is described by the area under the receiver operator characteristic (ROC) 
curve. This curve is a plot of true-positive versus false-positive predictions. For the PIM 
this area was 0.90. PIM discriminates well in a new populations of PICUs not used in the 
derivation of the initial score, therefore validating the PIM. In comparison, PRISM III [2] 
also discriminated well (ROC area=0.94) in the separate validation sample comprised of 
10% of patients from the 32 PICUs used in its development. 
PIM uses data present upon admission rather than use the worst values during the 
first 12 or 24 h after admission, as is done when using the PRISM III. Patients with lower 
predicted mortality scores upon admission who receive “bad” care and deteriorate within 
the first 24 h will be counted as unexpected deaths if admission scores are used, but will 
be counted as expected deaths if the most abnormal values in 24 hours are used. 
However values reflecting the physiological status present upon admission could 
reflect a transient state resulting from interventions during transport or in the operating 
room. To date, there is no consensus has been reached as to which approach is better.
Reliability  is  the  ability  of  a  score  to  predict  mortality  accurately  in  various 
subgroups  of  patients.  The  PIM  is  well  calibrated  in  each  decile  of  mortality  risk. 
However, when patients are categorized by diagnostic groups (for example in the group 
comprising  postoperative  non-cardiac  patients)  the  area  under  the  ROC  curve  was 
significant. The PIM discriminates quite well for trauma patients (ROC area=0.94), but 
not as well in cardiac patients (ROC area=0.83)27.
Another test of reliability is the ability of various raters to derive the same score 
when assessing a patient at the same point in time. The PIM and the PRISM III perform 
well on this evaluation criterion.
In a subset of 1182 children from a single Australian PICU, PRISM predicted 
118.6  deaths,  PIM  predicted  71.6  deaths,  and  there  were  78  actual  deaths23.  Over 
prediction  of  mortality  by  the  PRISM  score  could  be  because  the  centralized  care 
delivered by this large tertiary centre is superior. However poor performance of mortality 
prediction scores in countries where they were not developed has been shown in other 
studies36. 
The  PIM  is  a  score  derived  in  an  Australian  population  made  up  of  large 
centralized PICUs. Patients cared for in small community hospital ICUs may differ in 
ways  that  are  not  adjusted  for  by  the  score.  The  PRISM  III  was  developed  using 
randomly  selected  PICUs  while  ensuring  that  a  variety  of  ICU  characteristics  were 
present in the development sample. 
The  PIM  outperforms  the  PRISM  III  in  its  ease  of  use.  The  PIM  requires 
collection of only 8 variables upon admission. The PRISM III requires collection of the 
most abnormal (highest and lowest) values of 17 physiologic variables during the first 24 
h after admission plus 6 additional risk factors.  In recent times data collection has been 
made easier with automated data collection systems. The coefficients for the PIM are 
freely available,  whereas use of the PRISM III requires payment  of a fee.  With each 
update of the PRISM score, the coefficients have been readjusted to reflect differences in 
patient  outcomes  that  have developed as  processes  of care  and patient  characteristics 
change over time.
Both  the  PIM  and  the  PRISM  III  claim  that  comparison  of  observed  versus 
expected mortality among a group of PICUs is a beneficial technique for rating PICU 
performance.  Since  mortality  is  a  relatively  rarer  outcome,  in  both  the  PIM and  the 
PRISM III patient cohorts, the majority of care being delivered may not be assessed by 
mortality prediction scores. These scores do not predict other more common outcomes 
such as length of stay or functional status very well. Both the PIM and the PRISM III are 
not accurate for individual prognostication. 
The PRISM was found to predict 66% more deaths than the PIM in an Australian PICU 
possible due to highly centralized intensive care in Australia. The variables used by PIM that are 
not used by PRISM are the presence of a specified diagnosis, use of mechanical ventilation and 
the plasma base excess. The PRISM III 20 had an area under the ROC plot of 0.94 for both the 12-
h and 24-h models  –  but  may be considered to  be even more  complicated than the original  
version19. An annual license fee was collected for use of the PRISM scores. 
Treatment  given just  before  admission  to  intensive care  is  likely to  affect  admission  
scores (such as PIM) more than 24-h scores. For example, in a patient with shock, appropriate 
administration of fluid and sympathomimetics may increase blood pressure and restore the base 
excess  to  normal,  which  will  affect  the PIM score.  However,  if  this  treatment  improves  the  
patient‘s prognosis at  the time of admission to intensive care, it  alters the PIM score. It  was 
suggested that patients with a given severity-of-illness score may have a higher mortality rate if  
they have been extensively treated before they are admitted to intensive care 37, a problem known 
as lead time bias, but time spent in hospital before admission to intensive care was not found to 
be statistically significant when added to the PIM model. PRISM uses data collected over the first  
24 h after admission to intensive care (12 or 24 h for PRISM III), and many of the deaths occur  
during this time,  so that the score may be diagnosing death rather than predicting it  in some 
patients.       
Therefore in conclusion on reviewing the literature the PIM has been proved to be an  
adequate  indicator  of  the  risk  of  mortality  world  wide  in  the  subset  involving  critically  ill  
children.  
Materials and methods 
Study design  
              The design of the study was an observational prospective cohort study
Study population
 All children admitted into the Paediatric Intensive Care Unit (PICU) from 1st 
February  2007  to  31st September  2007  were  included  in  the  study.  There  was  no 
intervention in this study. All consecutive children were included in the study and none 
were excluded due to any reason. 
Study setting
This  study  was  performed  in  Paediatric  Intensive  Care  Unit  (PICU)  of 
Department of Child Health, Christian Medical College and Hospital, Vellore which is a 
multispecialty  tertiary  care  hospital  in  South  India.  The  paediatric  wards  have  133 
general beds and cater services to General Paediatrics, Paediatric Oncology, Paediatric 
Nephrology,  Paediatric  Endocrinology,  Developmental  Paediatrics  and  Paediatric 
Surgery. 
The PICU has eleven beds and five step down semi ICU beds. The PICU not only 
accepts  children  from all  above  mentioned  Paediatric  specialties  but  also  from other 
specialties such as Hematology, Urology, Plastic surgery and Cardiology. Children are 
received  directly  from the  Paediatric  Emergency  services  or  from General  Paediatric 
wards. Paediatric surgical patients are admitted either from their ward or from operating 
theatres. Out born neonates and inborn neonates aged over 72 hours are also admitted to 
the PICU. How ever paediatric population requiring post operative care in the field of 
cardiothoracic surgery and neurosurgery were managed separately under their respective 
ICUs.
The PICU is staffed by one senior consultant trained in intensive care, two junior 
consultants  and  five  medical  officers  who  work  in  shifts.  There  are  four  registered 
nursing staff per shift with the nurse: patient ratio of 1:3. This team also includes two 
respiratory therapists and one dialysis technician.  
The  intensive  care  unit  can  provide  the  following  modalities  of  treatment: 
ventilatory support, inotropic support, cardiovascular monitoring, central venous access, 
invasive CVP and arterial monitoring and ETCO2 monitoring. Peritoneal dialysis was the 
predominant  mode  of  renal  support  while  this  study  was  being  done.  Intermittent 
hemodialysis  and hemofilteration are technically possible and were being increasingly 
utilized.  Blood gas analysis was done in the Biochemistry department and was available 
24 hours of the day. 
Sample size
As per the statisticians advice a defined period of study was chosen before the 
onset of the study. This period was chosen as minimum of eight months. All children 
admitted under PICU for treatment during the period were included in the study.
Data collection
The PIM 2 variables were collected within one hour of admission into PICU as set 
out  for  PIM 2  score  (refer  appendix  1).  All  the  data  was  collected  by  the  primary 
investigator.  Patients with multiple admissions were included and regarded as separate 
admissions. Demographic  data,  physiological  data  and  the  clinical  diagnoses  were 
entered  at  the  time  of  admission.  Informed  consent  was  not  taken  as  there  was  no 
intervention in the study design. The admission diagnosis was entered and classified into 
various diagnostic groups consisting of CNS, respiratory, cardiovascular, gastrointestinal 
or  liver,  sepsis,  multi-organ  failure,  hematological,  poisoning,  metabolic,  renal,  post-
operative and others. The length of stay in PICU and final outcome (Death or transfer out 
of PICU) were entered later on. No extra tests were performed to meet the needs of this 
research since it considered non-collection as normal.
Statistical analysis  
PIM 2 SCORE was calculated for each patient using the software published in the 
website of www_sfar_org-scores-pim2.htm which is a free website available online. All 
the above collected DATA and the PIM 2 score were entered into the Statistical Package 
for the Social Sciences (Windows version 15.0; SPSS Inc, Chicago [IL], United States) 
and the DATA was analyzed.
Demographic  and  physiological  data  were  described  using  median  and 
interquartile ranges (IQRs) because they were not normally distributed. The individual 
mortality risk was predicted by a logistic regression equation and the overall predicted 
risk of intensive care unit mortality was subsequently calculated.
We tested the fit of PIM2 mortality prediction model in two ways – its ability to 
discriminate and calibrate the mortality risk. Discrimination refers to the ability of the test 
to calculate a higher mortality probability among non-survivors than survivors across the 
whole group. Calibration signifies how well the test predicts both mortality and survival 
across subcategories.
 
Discrimination  was  assessed  using  the  area  under  the  receiver  operating 
characteristic curve (ROC). Receiver operating characteristic (ROC) curve is a graphical 
representation  of  the  relationship  between  the  sensitivity  and  the  specificity  of  a 
particular test. This measure expresses how well the model distinguishes between patients 
who lived and those who died. The area under the curve (AUC) represents the overall 
accuracy of the test.  The larger the area the better is the test. An area under the ROC 
curve of  0.75 or  more  is  considered  clinically  useful,  and in  the  design  of  mortality 
prediction there is a trade off between the simplicity of the model (easier data collection 
and quality) and enhanced area under the ROC plot. An area under the ROC plot of 0.75 
means  that  a  randomly selected  non-survivor  would have a higher  PIM value  than a 
randomly selected survivor 75% of the time; it does not mean that prediction of death is 
correct 75% of the time. 
Calibration of PIM 2 score evaluates how well the model classifies patients into 
low,  medium,  and  high  risk  categories.  We evaluated  this  by  examining  a  Hosmer–
Lemeshow goodness of fit table where acceptable calibration is evidenced by a p value ≥ 
0.10. It compares model performance (observed versus expected) at five different risk 
intervals across the deciles of risk (i.e., predicted mortality <1%, 1–4%, 5–14%, 15–29%, 
or 30% or more) to test whether the model is biased (i.e. performs differentially at the 
extremes of risk). A non significant value for this test suggests an absence of such bias.
  We also calculated the Standardized Mortality Ratio (SMR) , which is the ratio 
of observed to expected death rates.  The overall expected death rate is the sum of the 
probability of death for each admission. Observed deaths included all children who either 
died  in  the  ICU  or  were  discharged  in  a  terminal  condition  at  parental  request. 
Confidence intervals (CIs) for the standardized mortality ratios were also calculated. An 
SMR value less than one would imply good performance of our PICU and value greater 
than one would imply poor performance.  On the other hand, an SMR less than 1 could 
be interpreted as an overestimation of mortality in the PICU by the PIM.   If the SMR 
was equal  to one or if  the  CIs included the value 1.0 then it  would indicate that the 
outcome of our patients was as predicted by PIM-2, indicating that the particular PICU is 
performing as par with the Australian PICU where it was developed initially.
                                          
                                                        RESULTS
A total number of 755 children were admitted into the Paediatric Intensive Care 
Unit (PICU) during the study period from 1st February to 31st September 2007.
Demographic pattern of the study population
There were 435 (57.6%) boys and 320 (42.4%) girls in the study population with 
the Male: Female ratio of 1.4:1 as shown table 1.
                                             
                                        Table1:- Gender distribution
Gender No. of children %
Male 435 57.6
Female 320 42.4
Total 755 100
Table 2:- Age wise distribution
The age wise distribution of the 755 children is shown in table 2. Majority of the 
PICU admissions were infants below 1 year of age contributing to 305(40%) of the study 
population. This was followed by the 1-5 year age group contributing 246 (33%) children 
and  6-10  year  and  11-15  year  age  groups  contributing  102  (14%)  children  each  as 
mentioned in the Table 2. The median age of the study group was 12.00 months with an 
interquartile range of 4-72months.
Table 3 shows that among the infants, neonates made up 30% (92 0f 305) of the 
admission.
Age group No. of  children %
Less than 1 year 305 40
1-5 years 246 33
6-10 years 102 14
11-15 years 102 14
Total 755 100
                              Table 3:- Age distribution of Infants
Graphical representation of the study population revealed that the age distribution of the 
study population did not follow a normal distribution curve as shown in the Figure 4. 
Distribution pattern of the admissions 
Majority  of  children  got  admitted  from  Paediatric  accident  and  emergency 
services making up 59.4% (449 of 755) followed by ward transfer- in making up 37.3% 
(281of 755). Transfer in for post operative monitoring from operative theatres constituted 
2.8% (21 of 755) of the PICU admissions as shown in the table 4 and Figure 5. 
                                    
Age group
No    of 
Children
%
Less than 1month 92 30
1-6 months 135 44
7- <12months 78 26
Total 305 100
                                  Table 4: - Pattern of PICU admissions
Admissions from
No. of 
children
%
CASUALTY 449 59.4
WARD 281 37.3
OT 21 2.8
OPD 3 0.4
BMTU 1 0.1
Total 755 100
Table 5:- Distribution of admissions based on primary admitting units
                                                                 
Table 5 and Figure 6 show the distribution of the children according to the admitting unit. 
82.2% (621 of 755) were from the three general Paediatric units, 5.6 %( 42 of 755) from 
Paediatric oncology unit, 1.4% (10 of 755) from Paediatric nephro-logy unit, 0.5% (4 of 
755) from Paediatric Endocrinology.  Paediatric surgery patients made up 7.5% (56 of 
755). Rests of the specialties contributed 2.8% (22 of 755) to PICU admission.  
Disease pattern in PICU
Table 6 and Figure 7 shows that Sepsis syndrome top the list of admissions in 
PICU constituting 142 of 755 (18.8%) admissions. This was followed by central nervous 
system illness in 131 of 755 (17.4%), respiratory illness in 97 of 755 (12.8 %), GI and 
hepatic illness in 94 of 755(12.5%). Poisoning and envenomations contributed 70 of 755 
(9.2%), malignancy by 52 of 755 (6.9 %), cardiovascular illness by 45 of 755 (6 %), 
Surgical illness by 31 of 755(4.1%), renal illness by 26 of 755 (3.4%), Hematological 
illness  by  20  of  755 
(2.6%).  Miscellaneous 
illnesses  contributed  to 
37of 755(6.3%).    
 
         
Admitting 
Units
No. of children %
CH I 173 23.0
CH II 224 29.6
CH III 224 29.6
PAED.SURGERY 56 07.5
PAED. ONCOLOGY 42 05.6
PAED.  NEPHROLOGY 10 01.4
PAED.ENDOCRINOLOGY 4 00.5
HAEMATOLOGY 8 01.0
MISC 14 01.8
Total 755 100
Table : 6 Disease Pattern In PICU
Primary 
System 
Involved
Number %
Sepsis/MODS 142 18.7
CNS 131 17.3
Resp 97 12.8
GI 94 12.4
Poisoning 70 9.2
Malignancy 52 6.8
CVS 45 5.9
Post op 31 4.1
Renal 26 3.4
Hemat. 20 2.6
Rheumat. 10 1.3
Endo. 9 1.1
Accidents 8 1
IEM 5 0.6
Immunodef. 3 0.3
Misc. 12 1.5
Total 755 100
Frequency of PIM2 score variables
Table 7 shows that 725 (96%) children were emergency admissions and only 30 
(4%) were elective admissions. 66 (8.7%) children were admitted for Post- procedure 
monitoring. There was no single admission due to cardiac bypass. Among the other PIM 
variables, 73 of 755 (9.7%) had high risk diagnosis and 24 of 755 (3.2%) had low risk 
diagnosis. Rest of the 658 children could be coded neither as high risk nor low risk. 
 At admission 27 children (3.7%) had dilated fixed pupils, 254(33.6%) children 
required mechanical ventilation within one hour admission into PICU and 125(16.6%) 
admissions came in shock. 235 (31%) children had Base excess samples results in the 
first hour of their admissions. Fio2/PaO2 was available for 29.7% (224 of 755). 
Table -8 shows the distribution of the children with the high risk diagnoses. Liver 
failure tops the list of high risk category (19 of 73) which was followed by leukemia after 
the first induction (18 of 73). Table -8 shows the distribution of children with low risk 
diagnoses.  Bronchial asthma (13 of 24) tops the list.
Duration of PICU stay
Figure-7 and Table-9 show the duration of PICU stay. Out of the 755 children admitted, 
586 (78%) had PICU stay of < 72hours, of which 96 (13%) stayed less than 24 hours and 
490 (65%) stayed between 24-72hours. The median duration of PICU stay was 48 hours 
with range of 1 – 75 days.
                               Table 9:- Duration of PICU stay 
                                        
                                        
Duration of stay No of Children %
< 24 hours 96 13
24-72hours 490 65
4-7days 126 16
8-14days 34 5
>14 days 9 1
Total 755 100
Figure 8 and table 10 show the relationship between the duration of PICU stay and the 
percentage  of  mechanical  ventilation.  There  was  a  positive  relationship  between 
ventilatory support received and the duration of PICU stay. 
                    
        Table 10:- Duration of stay Vs Mechanical ventilation 
Among the ventilated children, electively admitted children required lesser duration of 
ventilation compared to emergency admissions.  On the extremes of duration of PICU 
stay, mortality seems to be comparatively increased than definite as seen in table 11.
                        Table 11: Duration of stay Vs mortality  
Mechanical ventilation
Duration of 
PICU stay
No (%) Yes (%) Total
<24 hours 275 (76.2) 86(23.8) 361
24-72hours 158(70.3) 67(29.7) 225
72-hours -1 
week
52(41.3) 74(58.7) 126
1-2 weeks 13(38.3) 21(61.7) 34
>2weeks 3(33.3) 6(66.7) 9
Total 501(75.6) 254(24.3) 755
Duration of PICU 
stay
Survival Mortality
<24hours 64(67%) 32(33%)
24-72hours 386(79%) 104(21%)
72hours -1week 95(75%) 31(25%)
1-2weeks 22(65%) 12(35%)
>2weeks 4(44%) 5(56%)
Total 571 184
                                 Table 12:-Outcome in PICU
This  table  shows the  outcome of  the 
755 children admitted  to PICU.  184 
(24.3%)  children  had  an  adverse 
outcome, of which death comprised of 
104  (13.8%)  and  discharged  against 
medical advice or by parental request 80(10.5%).  Since these children were discharged 
in a terminal condition for the purpose of analysis we have considered them as mortality. 
The overall mortality was 24.3%.
Table  13  and  Figure  10  show  the  distribution  of  diseases  among  the  children  who 
succumbed. Out of the 184 children, 62(33.6%) had sepsis with multiorgan dysfunction 
group followed by neurological illness in 25 (13.6%). Gastrointestinal-  hepatic illness 
and malignancy constituted 19 (10.3%) each and respiratory illness in 16 (8.7%). Only 
one child with surgical problem had died. 
             
              Table 13 :- Disease status and the incidence of mortality
Outcome
No. of 
Children
%
Survival 572 75.6
Death 104 13.8
Discharged at 
request 80 10.5
Total 755 100
Disease
No  of 
children
No of 
deaths
% of 
total 
mortality
% of 
mortality 
individual 
disease 
group
Sepsis  / MODS 142 62 33.7 44
Accident and 
injury
8 1 0.5 12.5
CVS 45 13 7.1 29
Resp 97 16 8.7 16.5
CNS 131 25 13.6 19.0
Renal 26 1 0.5 3.8
Haemat 20 11 6 55
GI/Liver 94 19 10.3 20
Endo 9 2 1.1 22
Poisoning 70 5 2.7 7.1
Malignancy 52 19 10.3 36.5
IEM 5 2 1.1 40
Surgical 31 1 0.5 3.2
Misc 12 2 1.1 16.6
Immunodeficiency 3 2 1.1 66.7
Rheumat 10 3 1.6 30.0
Total 755 184 100
Table-  13  also  shows  the  deaths  in  the  different  diagnostic  groups.  Out  of  the  142 
children  admitted  with  sepsis  and  MODS  62(44%)  had  succumbed.   Out  of  the  20 
children  with  hematological  disorders  11(55%)  and  among  the  3  children  with 
immunodeficiency diseases 2 (66%) had died. 19 out of the 52 children with malignancy 
also had an adverse outcome.  However, hematological illness contributed only 6% of the 
overall mortality. Cardiovascular, respiratory and CNS disorders showed a mortality of 
29%,  16.5% and  19.0% respectively.  Out  of  70  children  with  poisoning  and enven-
omations 5(7.1%) had an adverse outcome. Lowest mortality was seen among the post-op 
surgical patients.
The performance of PIM2 score
During  the  study period  184 (24.3%) children  out  of  755  patients  died.  The  overall 
expected deaths as predicted by PIM score was 183.9 with an area under the receiver 
operating characteristic curve of 0.839 with a 95% CI of 0.804 and 0.874 which was 
statistically significant (Figure-11).   
Table 14: Calibration of PIM2 SCORE model by Hosmer Lemeshow 
goodness of Fit test
Outcome Survival Mortality
Decile Observed Expected O:E ratio Observed Expected O:E ratio
1 65 57 1.14 0 8 0
2 52 49.8 1.04 5 7.2 0.69
3 44 44.5 0.99 7 6.5 1.08
4 58 52.3 1.11 2 7.7 0.26
5 74 68.8 1.08 5 10.2 0.49
6 64 60.8 1.05 6 9.2 0.65
7 67 71.5 0.94 16 11.5 1.39
8 54 63.6 0.85 22 12.3 1.79
9 56 59.5 0.94 20 16.5 1.21
10 37 43.2 0.86 101 94.8 1.06
Total 571 571 1 184 183.9 1.00
Hosmer and Lemeshow Test
32.632 8 .000
Step
1
Chi-square df Sig.
The calibrative capacity of the Paediatric Index of Mortality 2 (PIM2) score was assessed 
by  the  Hosmer  lemeshow  goodness  of  fit  test  in  which  predicted  mortality  risk  as 
assessed by PIM2 score was divided into ten deciles. It was compared with observed 
mortality. Table 14 shows the calibration of PIM2 score model of our study.Figure-12 
shows the graphic representation of the calibration. The total observed mortality was 184 
and the predicted mortality was 183.9 in our study with a standardized mortality ratio of 
1.070 with 95% confidence interval 1.060 – 1.093. How ever closer look at the values 
show that the PIM2 score predicts  more death in the low risk group compared to the 
observed mortality and under predicts mortality in the high risk group. The chi square 
value for our study was 32.6 with a p value of <0.001 suggesting poor calibration of  
PIM2 score in our study population. 
                                                      Discussion
Intensive care treatment for critically ill children is being increasingly recognized 
as a need in India. It is no surprise therefore, that Paediatric Intensive Care is now a 
rapidly developing specialty with intensive care units being established in several places. 
While those involved in the delivery of intensive care to critically ill  children 
constantly  strive  to  improve  the  standards  of  care  given  to  a  sick  child,  they  are 
challenged by limited resources in terms of space, technology, manpower and finances. 
Admission into the intensive care unit often, is only the beginning of various other ICU 
interventions which can be difficult to limit once they are initiated. Such interventions 
come  at  a  huge  cost  to  the  family  and  the  outcome  is  uncertain  despite  all  these 
interventions.  Since the cost of health care in ICU has gone up dramatically,  correctly 
identifying those children who are salvageable from moribund group of children becomes 
necessary for implementation and rationing of effective medical therapy. 
This problem of scarce resources and the constant urge to utilize the resources 
optimally has led us to this study, to assess a scoring system which may guide us to  
prognosticate  our  patients.  Additional  benefit  would  be  that  this  may  enable  us  to 
compare the performance of our PICU with others.
  
Literature  review  revealed  that  there  are  two  important  scores  available  for 
paediatric use. Out of the two scores, the Paediatric Index Mortality 2 Score (PIM-2) is 
easy to collect since it has minimum number of variables; the data is to be collected  at 
the time of admission to the intensive care unit or within the first hour; the software for  
calculating the PIM expected mortality is freely available on the internet for calculation. 
Though treatment provided in the emergency department could influence the outcome, 
the treatment provided in the PICU will not be influencing PIM 2 scoring system. To our 
knowledge, validation of Paediatric Index of Mortality 2 score has been done in only one 
study in Indian children but has been validated extensively elsewhere40-44.
The study was done in PICU of Christian Medical College and Hospital, Vellore 
which is a major tertiary care centre in South India. The PICU has 11 beds and receives 
sick children with both medical and surgical diseases. The unit is busy with an admission 
rate of over 1200 children per year. The unit is equipped with ventilators, monitors and 
facilities for dialysis.  Since this is a referral hospital’s intensive care unit the patient  
population represents a good amount of case mix and disease severity requiring intensive 
care.  The overall  mortality  lies  around 20-25 % which  is  high  compared  to  western 
figures. The reason for the high mortality could be because the children are sicker or 
because the quality of intensive care is not sufficient for the degree of illness. The patient 
population could also be very different in terms of the conditions that are prevalent here. 
The health seeking behaviour of the families when a child falls sick which depends on the 
cultural background from where they come from, the educational status, the finances, the 
primary health care accessible, the referral system available etc. could also influence the 
outcome.   Hence  we  postulated  that  our  children  would  be  different  from  those  in 
Australian ICUs and a scoring system developed in them may not perform well in our 
scenario. 
 During the study period, there were 755 children, aged from 72 hours to 15 years 
admitted to the PICU who were all included for the final analysis. The median age was 
12 months with an interquartile range of 4-72 months.  Infants made up 40 %( 305) of the 
study population with neonates comprising 30% of them. This compares with the study 
population in the original PIM2 study done in Australian PICUs which had 42% infants. 
But in that study, the proportion of neonates was only 13%. The numbers of children in 
the rest of the age groups were also similar to original PIM2 study -33% compared to 
28% in  the  1-5year  age  group,  14% in  both  the  6-10yr  and  11-15  yr  age  group  as 
compared to 14 and 15% respectively in the Pearson et al study28. The age distribution of 
our  study population  was  also similar  to  the  only other  Indian  study done on PIM2 
scoring  system  by  Thukral  et  al45.  The  age  distribution  did  not  follow  the  normal 
distribution curve and this has been noted in other studies as well.  
There were 435 (57.6%) boys and 320 (42.4%) girls with the male: female ratio of 
1.4:1 showing preponderance for male gender. It was similar to the gender distribution of 
our hospital admissions. It may due to the cultural importance given to male gender for 
inheritance and seeking medical care for them more than for the girls. The study by Choi 
et al41 from Hong Kong also showed a similar phenomenon.
Distribution of the study children according to the admitting units as described 
under results showed good amount of case mix in this study. As compared to the Pearson 
et al28 study in which the proportion of children with surgical problems was 40%, our 
study  showed  that  a  significant  number  of  children  belonged  to  the  medical  units 
(92.5%). In their study 42% of the admissions were received from operating theater (OT), 
while  only  2.8% of  our  population  was  received  from the  operating  theatre.  In  our 
hospital cardiothoracic and neurosurgical units have their own separate ICUs where their 
post-operative patients are looked after and therefore they were not included in our study. 
This situation is very different from the ICUs included in the Pearson et al28 study but not 
different from that described in the other Indian study by Thukral et al45 and Turkey study 
by Ozer et al40. In general, PICUs in developing countries received children with medical 
problems mainly tropical infectious diseases seen in that part in significant numbers than 
in developed countries.
             
Sepsis  with  multiorgan  dysfunction  (18.8%)  was  the  predominant  reason  for 
admission to our ICU. There could have been 2 reasons for this phenomenon. As we have 
seen earlier, 30% of admissions were in the neonatal age group and the most common 
diagnosis among them was sepsis. Apart from this, a dengue epidemic and an increased 
occurrence of Rickettsial infections that was encountered during the time the study was 
undertaken, also have contributed to significant number of admissions with shock and 
with  MODS.  Central  nervous  system illness  (17.4%)  was  the  second  most  common 
diagnosis  in  our  study.  It  comprised  of  status  epilepticus,  viral  encephalitis,  Guillain 
Barre syndromes and severe bacterial  meningitis.  There was a slight  reduction in the 
respiratory illnesses (12.8%). Acute gastroenteritis with shock and/or other complications 
contributed much to GI and hepatic illnesses (12.5%) apart from hepatic encephalopathy 
and  massive  GI  bleeds.  Surprisingly  poisoning  and  envenomation  contributed  9.2%. 
Snake  bite,  scorpion  sting  envenomations,  Organo-phosphorus  poisoning,  accidental 
ingestion of antipsychotic  drugs, anti  – histamines,  camphor contributed significantly. 
Surgical emergencies and post operative monitoring for major surgical illnesses made up 
4.1%. Acute lymphoblastic leukemia significantly contributed to malignancy (6.9%). 
The distribution pattern of the diseases in our PICU was quiet different from the 
study by Pearson et al28, where sepsis and other infectious diseases were not represented. 
The  original  PIM2 study group  comprised  mainly  of  surgical  patients  with  low risk 
diagnoses according to PIM2 study authors themselves. However,  a predominant sepsis 
and  other  infectious  diseases  pattern  seen  in  our  study  is  similar  to  others  done  in 
developing countries like Thukral et al in India (37.2%) and Ozer et al40 in Turkey(41%). 
This represents the pattern of prevalence of diseases in developing countries which is 
quite  different  from developed countries.  12.8% of  our  children  only had respiratory 
illness  as  the  main  diagnosis  as  compared  to  21.6%  reported  by  Pearson  et  al22 
(Australia), 14.97% by Pearson et al28 (UK), 33% by Ozer et al (Turkey), 25.6 %  by 
Thukral et al45 (India), 39.6% by Choi et al40 ( Hong Kong). The likely reason for the low 
respiratory illnesses seen in our study population could be due to the fact that the study 
was completed just before the peak RSV season and/or due to the a reduction in the 
occurrence  of  severe  ARIs  related  to  the   increasing  utilization  of  Haemophilus 
influenzae b vaccine.    
In our study, 254(33.6%) children out of 755 were ventilated within one hour of 
admission into PICU. 
Out of 755 children, 571(75.7%) children survived and were discharged well from 
the intensive care unit.  Of 184(24.3%) children who succumbed 104(13.8%) children 
died in the ICU and 80(10.5%) were discharged in a terminally ill condition at parental 
request.   We have considered  those  who were  discharged in  a  terminal  condition  as 
mortality.  Out of the 184 children, 62(33.6%) had sepsis with multiorgan dysfunction 
group followed by neurological illness in 25(13.6%). Gastrointestinal- hepatic illness and 
malignancy constituted 19(10.3%) each and respiratory illness in 16(8.7%). Only one 
child (0.5%) from the surgical unit with extensive burns had died. In the original PIM 
study by Pearson majority of the deaths was due to cardiac condition (24.4%), followed 
by injury (15.6%), respiratory illness (14.5%) and neurological  illness (9.05%).  Non 
cardiac post operative patients contributed to the 4.34% of mortality. 
The overall mortality seen in our ICU is comparable to the figures reported by 
Thukral et al45 from India (35.3%) and Ozer et al40 from Turkey (27.6%).  Other similar 
studies on prognostic scores however report much lower death rates: Pearson et al28 (UK) 
7.955%, Pearson et al22 (Australia) 5.31%, Reinoul et al42 (Netherlands) 6.6%, Martha et 
al43 (Brazil) 7.83%, Choi et al41 (Hong Kong  ) 2.64%.
Given the characteristics of our patients we did not expect the PIM to perform 
well in our intensive care unit and our null hypothesis was that PIM2 scoring system will  
not  predict  mortality  in  our  Indian  study  population.  However  the  analysis  revealed 
interesting results.
Performance of PIM2 Score 
The overall expected deaths as predicted by PIM 2 score was 183.9 with an area 
under the receiver operating characteristic curve (ROC) of 0.839 with a 95% CI of 0.804 
and 0.874 which was statistically significant.  This was comparable to the PIM2 score 
discrimination capacity achieved in Australian PICUs by Pearson et al with AUC of 0.90 
( 95% CI of 0.89 -0.91). Similar outcomes have been observed in other studies that have 
evaluated both PIM and PIM2.  In the study by Thukral et al from Delhi, the AUC (95% 
CI) for PIM was 0.82(0.76-0.88) and for PIM2 0.81 (0.75-0.87).  In a similar study on 
validation of PIM2 score by Eulmesekian et al44 in Argentina on 1574 intensive care 
patients with 41 deaths the AUC was reported to be 0.89 (95% CI of 0.89 – 0.92) .  
Furthermore, recently wolfler et al46 from Italy in their study validating PIM2 in 3266 
children from 18 PICUs have reported an AUC of 0.89 (95% CI of 0.86 – 0.91). All these 
studies have concluded that both PIM and PIM 2 had adequate discriminative ability. The 
only exception is the study by Ozer et al40 in Turkey in which the AUC was only 0.69 
(95%CI of 0.56 to 0.82) suggesting PIM had poor discriminatory capacity in their study 
population.  However,  the study was done in  an ‘Infantile  intensive  care unit’  among 
children aged 1 month- 24 months, with the mortality of over 50%.      
The standardized mortality ratio (SMR) calculated by PIM 2 score for our study 
group was  1.077 with  95% CI  of  1.060 –  1.093.  This  was  comparable  to  the  SMR 
predicted in Australian PICU by Pearson et al22 with a value of 1.00 (95% CI of 0.95 
-1.05). It suggests that our PICU performance was comparable to the PICUs where the 
original PIM2 score was developed.
Similar outcomes have been observed in other studies that have evaluated both 
PIM  and  PIM2.   The  study  on  validation  of  PIM2  score  by  Eulmesekian  et  al  in  
Argentina reported a SMR of 0.85 (95%CI 0.60 – 1.1). The earlier PIM validation in UK, 
Hong Kong, Netherlands reported SMRs of 0.87(95%CI 0.81-0.94), 0.61(95%CI 0.50-
0.77), 0.88(95%CI 0.55-1.20) respectively. However SMRs reported from Turkey, Brazil 
and  India  have  shown  values  of  3.68  (95%CI  3.08-4.28),  1.26(95%CI  0.87-1.77), 
1.57(95%CI 1.24-1.59) respectively. 
The calibration of PIM2 score as tested by Hosmer Lemeshow goodness of fit test 
for  our  study  population  showed  a  chi  2  value  of   32.6  with  a  p  value  of  <0.001, 
suggesting highly significant result. This means that the calibration of the PIM2 score 
was poor  in  our study population.  Further  analysis  of the distribution  of PIM2 score 
showed  that  the  mortality  was  over  predicted  in  the  low  risk  categories  and  under 
predicted in the high risk categories. This may be attributable to the observation that only 
97 of 755 (12.9%) children in the study population were allotted to risk groups either 
high or low risk. The high risk groups in the our scenario like sepsis, dengue hemorrhagic 
fever with dengue shock syndrome, Rickettsial infection in septic shock, cerebral malaria, 
scorpion sting,  OP poisoning,  rheumatic  heart  disease  with  multiple  valvular  lesions, 
hemolytic uremic syndrome, immuno suppression for chronic illness etc are not given 
enough high risk weightage in the PIM2 score. This could have led to the poor calibration 
of PIM2 scoring with effect  of  under  prediction  of  mortality  in  the  high  risk group. 
Similar effect of over prediction in the low risk group could have produced an opposite 
effect. 
Poor calibration of PIM and PIM2 has been reported in other studies done earlier 
elsewhere.  Although the study done by Choi et al from Hong Kong reported satisfactory 
overall calibration of PIM ,  there was an over estimation of mortality in 0% - <25% and 
50 -<75% risk category.  Conclusion could not be drawn in the other risk categories in 
view of wide range of 95% CI for SMR and insufficient sample size. Ozer et al from 
Turkey reported poor discrimination  of PIM in their  infantile  intensive  care unit,  but 
satisfactory overall calibration of PIM with a chi 2 value of 10.9 and p value of 0.20. 
Reinoud et al from Netherlands reported an underestimation of mortality among the low 
risk group (1 -<5%), overestimation in >30% risk category with an overall satisfactory 
calibration (chi 2 4.92 p=0.77) in their study population. Martha et al from Brazil and 
Eulmesekian  et  al  from Argentina have also reported poor calibration of PIM2 score 
among their study population. The only Indian study done by Thukral et al in New Delhi 
revealed a chi 2 value of 7.64 (p=0.47), however  95% CI of SMRs were wide.   How 
ever studies from UK (PIM), Italy on PIM 2 had good calibration. This could be due to 
major  surgical  population  in  the  developed  countries  in  contrast  to  severe  medical 
conditions seen in the developing countries.  The higher SMR in developing countries 
may be attributed to prevalence of infectious  diseases, predominantly sepsis  as major 
cause  of  admission,  malnutrition,  chronic  illness,  delayed  referral,  absence  of  good 
transport facilities for sicker children, scarce resources, both physical and human staffing 
of PICUs and differences in the practice guidelines in the various PICUs.      
Limitations of the study
In our study base excess analysis was not done to all unless clinically warranted. 
Arterial blood gas analysis was routinely done only for those patients who were intubated 
on arrival and subsequently ventilated. Some of the blood gases were done after the first 
hour and were not included in the study. As we did not have an Fiao2 analyzer, those 
who were on high flow oxygen could not be assessed for value of Fio2 and the variable in 
PIM 2 scoring system was entered as 0. This could have underestimated the severity of 
the  illness.  During  our  study  period,  there  was  a  Dengue  epidemic  and  increased 
prevalence of Rickettsial infection. Though these patients appeared stable initially, some 
of them later went into refractory shock with ongoing third space loss fluid loss and 
haemorrhage.  This  group  of  children  could  have  had  an  under  estimation  of  their 
predicted mortality.
Our  study  shows  that  PIM  had  good  discriminatory  capacity  in  our  patient 
population and therefore given its advantages is a good scoring model applicable for our 
patients. However, we observed that the PIM2 did not calibrate well with an under
prediction of mortality in the high risk group and over prediction in the low risk 
group.  Further studies are needed to identify high risk diagnosis in our population. This 
can be followed up with studies that evaluate PIM2 with those diagnoses coded as high 
risk in the PIM2 model. Other areas of research would be to determine if PaO2 could be 
substituted with Sa02 in the PIM2 variable 100*FiO2/PaO2, this would further improve 
entries of this particular PIM2 variable. The possibility and predictability of PIM2 score 
with these modified variables should be explored in the future studies. This may result in 
modifying or adapting the existing PIM 2 score in a way that their current functioning in 
the developed world is not affected but are appropriate for use within the developing 
world. 
                                                        
   
             Conclusions
• PIM 2 score performed well in predicting deaths well among the children admitted to 
the Paediatric Intensive Care Unit. 
• The Standardized Mortality Ratio of the study population was 1.077 (95% CI 1.060 – 
1.093) showing the performance of the PICU to be comparable to the Australian 
PICUs where PIM2 was developed.
• PIM2  model  calibrated  poorly  in  our  study  population  as  tested  by  Hosmer 
Lemeshow goodness of fit test.  
• Further studies evaluating a modified and adapted PIM2 model that incorporates the 
different high risk diagnoses seen in our population are needed for better calibration.
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Appendices
APPENDIX: 1
Paediatric index of mortality 2 – instructions for use27 
PIM2 is calculated from the information collected at the time a child is admitted 
to  your  ICU. Because  PIM2 describes  how ill  the  child  was  at  the  time  you  started 
intensive care, the observations to be recorded are those made at or about the time of first 
face-to-face (not telephone) contact between the patient and a doctor from your intensive 
care unit (or a doctor from a specialist paediatric transport team). Use the first value of 
each variable measured within the period from the time of first contact to 1 h after arrival 
in your ICU. The first contact may be in your ICU, your emergency department, a ward 
in your own hospital, or in another hospital (e.g. on a retrieval). If information is missing 
(e.g. base excess is not measured) record zero, except for systolic blood pressure, which 
should  be  recorded  as  120.  Include  all  children  admitted  to  your  ICU  (consecutive 
admissions). 
Coding rules. These rules must be followed carefully for PIM2 to perform reliably:
1.   Record SBP as 0 if the patient is in cardiac arrest,  record 30 if the patient is 
shocked   and the blood pressure is so low that it cannot be measured. 
2.   Pupillary reactions to bright light are used as an index of brain function. Do not 
record an abnormal finding if this is due to drugs, toxins or local eye injury. 
3.   Mechanical  ventilation  includes  mask  or  nasal  CPAP  or  BiPAP or  negative 
pressure ventilation.
4.   Elective admission. Include admission after elective surgery or admission for an 
elective  procedure  (e.g.  insertion  of  a  central  line),  or  elective  monitoring,  or 
review of  home  ventilation.  An ICU admission  or  an  operation  is  considered 
elective if it could be postponed for more than 6 h without adverse effect. 
5.   Recovery from surgery or procedure includes a radiology procedure or cardiac 
catheter.  Do  not  include  patients  admitted  from  the  operating  theatre  where 
recovery from surgery is not the main reason for ICU admission (e.g. a patient 
with a head injury who is admitted from theatre after insertion of an ICP monitor;  
in this patient the main reason for ICU admission is the head injury). 
6.  Cardiac bypass. These patients must also be coded as recovery from surgery.
7.  Cardiac  arrest  preceding  ICU admission  includes  both  in-hospital  and  out-of-
hospital arrests. Requires either documented absent pulse or the requirement for 
external cardiac compression. Do not include past history of cardiac arrest. 
8.  Cerebral  haemorrhage  must  be  spontaneous  (e.g.  from  aneurysm  or  AV 
malformation).  Do  not  include  traumatic  cerebral  haemorrhage  or  intracranial 
haemorrhage that is not intracerebral (e.g. subdural haemorrhage). 
9.  Hypoplastic  left  heart  syndrome.  Any  age,  but  include  only  cases  where  a 
Norwood procedure or equivalent  is or was required in the neonatal  period to 
sustain life. 
10. Liver  failure  -  acute  or  chronic  must  be the  main  reason for  ICU admission. 
Include patients admitted for recovery following liver transplantation for acute or 
chronic liver failure. 
11. Neuro-degenerative disorder. Requires a history of progressive loss of milestones 
or a diagnosis where this will inevitably occur. 
12. Bronchiolitis.  Include  children  who  present  either  with  respiratory  distress  or 
central apnoea where the clinical diagnosis is Bronchiolitis. 
13. Obstructive  sleep  apnoea.  Include  patients  admitted  following  adenoidectomy 
and/or tonsillectomy in whom obstructive sleep apnoea is the main reason for ICU 
admission (and code as recovery from surgery).
Appendix 2: PIM2 Study Proforma
A STUDY ON THE VALIDATION OF PAEDIATRIC INDEX OF MORTALITY 2 
(PIM2) SCORE IN THE PEDIATRIC INTENSIVE CARE UNIT OF CMC, 
VELLORE
Name :                                        Age:                            Hospital No:-
Date of admission:    .    .            Time:
Admission from:-  Ward / Casualty /  Operation Theatre /  Other
Unit:-  CH I / CH II / CH III / Paed  Surgery / Haematology / Paediatric  Oncology /
            Paed Nephro / Orthopaed  /  Trauma /  Plastic surgery / ENT / Others
Diagnosis :- 
Length of stay:-
PIM 2 SCORE
Paediatric index of mortality 
Variables Values ( 1 – yes, 0 – no)
Elective admission 
Recovery post procedure
Cardiac bypass
High risk diagnosis
Low risk diagnosis
No pupillary response to bright light 
(>3 mm and  both fixed)
Mechanical ventilation 
(at any time during the first one hour)
Systolic blood pressure (mm of Hg)
Base Excess (mm of Hg)
(arterial or capillary blood)
FiO2*100/PaO2(mm of Hg)
Outcome : 
Death
Discharge at request 
Transferred to Ward  
Appendix 3: Online PIM 2 calculator
http://www.sfar.org/scores2/pim22.html
PIM 2 (Paediatric Index of Mortality) 
Variables (help)
Values (1 if Yes, 0 
otherwise)
Beta
Elective admission
Recovery post procedure
Cardiac bypass
High risk diagnosis
Low risk diagnosis
No response of pupils to bright light
(> 3 mm and both fixed)
Mechanical ventilation
(at any time during first hour in ICU)
Systolic Blood Pressure (mmHg) 0.01395
Base Excess (mmHg)
(arterial or capillary blood)
0.1040
FiO2*100/ PaO2 (mmHg) 0.2888
.. 
Predicted Death Rate : . 
... .. .
  Clear 
Logit = (-4.8841) + (values * Beta) + (0.01395 * (absolute(SBP-120))) + (0.1040 * (absolute base 
excess)) + (0.2888 * (100*FiO2/PaO2))
Predicted death rate = eLogit/ (1+eLogit)
Appendix 4: Coding for the master Sheet
A: Name of the patient (Name)
B: Sex of the patient (sex)
C: Age of the patient in years (age) 
D: Age of the patient in months (Months) 
E: Time of Admission (TOA)
F: Hospital Number (H.No)
G: Date of admission (DOA)
H: Date of Discharge (DOD)
I:  Length of stay in PICU (Length of stay)
J: Source of admission (FROM)
K: Admitting Unit (UNIT)
L: Elective admission(EA) (1-yes,0-no)
M: Recovery post procedure (RPP) (1-yes, 0-no)
N: Post cardiac bypass (CB) (1-yes,0-no)
O: High risk diagnosis at admission (HIGH RISK) (1-yes,0-no)
P: Coding for the High risk (risk No)
Q: Low risk diagnosis at admission (LRD) (1-yes,0-no)
R: Coding for the low risk (risk No)
S: No pupillary response (No response of pupils to bright light (> 3 mm and both fixed)) 
(1-yes,0-no)
T: Mechanical ventilation (at any time during first hour in ICU) (MV) (1-yes,0-no)
U: Systolic Blood Pressure (mmHg) (Sys.BP)
V: Base Excess (mmHg) (arterial or capillary blood) (BASE EXCESS)
W: FiO2*100/ PaO2 (mmHg) (OI)
X: Predicted Death Rate (PIM2)
Y: Outcome of the patient (OUTCOME) (DAMA,TO,DEATH)
Z: Coding for the Outcome (outcome no) (1- Death/DAMA,0-TO)
AA: Primary Diagnosis (PRIMARY DIAGNOSIS)
AB: Coding for the primary diagnosis (coding)
AC: Secondary diagnosis (SECONDARY DIA)
AD: Coding for the secondary diagnosis (CODING)
AE: Tertiary diagnosis(TERTIARY DIAGNOSIS)
AF: Primary system of illness(PRIMARY SYSTEM OF ILLNESS)
AG: Categorization of the PIM2 into five groups(1 to 5)
